Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(R)-(+)-2-chloropropionamide + H2O
(+)-2-chloropropionic acid + NH3
(R)-2,2-dimethyl cyclopropanecarboxamide + hydroxylamine
(R)-2,2-dimethylcyclopropane hydroxamic acid + NH3
(R)-2-chloromandelamide + H2O
(R)-2-chloromandelic acid + NH3
(R)-lactamide + H2O
lactate + NH3
about 30% of the activity with (S)-lactamide
-
-
?
(R,S)-2-(3-benzoylphenyl)propanamide + H2O
(S)-2-(3-benzoylphenyl)propanoic acid + NH3
-
enantioselective for the S-enantiomer
-
-
?
(R,S)-2-phenylpropionamide + H2O
(S)-2-phenylpropionic acid + (R)-2-phenylpropionamide + NH3
(R,S)-2-phenylpropionamide + H2O
(S)-2-phenylpropionic acid + NH3
-
the enzyme is highly S-stereoselective for 2-phenylpropionamide, and the racemic amide is converted to the corresponding S-acid with an enantiomeric excess of over 95% at 50% conversion of the substrate
-
-
?
(R,S)-ketoprofen amide + H2O
(S)-ketoprofen + NH3
-
the enzyme hydrolyzes S-ketoprofen amide to its corresponding acid in an absolutely enantioselective manner
-
-
?
(R/S)-2,2-dimethylcyclopropanecarboxamide + H2O
(R)-2,2-dimethylcyclopropanecarboxylic acid + (S)-2,2-dimethylcyclopropanecarboxyamide
-
-
-
-
?
(R/S)-piperazine-2-carboxamide + H2O
(S)-piperazine-2-carboxylic acid + (R)-piperazine-2-carboxamide
-
-
-
-
?
(S)-(-)-2-chloropropionamide + H2O
(-)-2-chloropropionic acid + NH3
(S)-(-)-2-hydroxy-2-(trifluoromethyl)-butanamide + H2O
(R)-(+)-2-hydroxy-2-(trifluoromethyl)-butanoic acid + NH3
-
stereospecific reaction
enantiomerically pure product
-
?
(S)-(-)-3,3,3-trifluoro-2-amino-2-methylpropanamide + H2O
(R)-(+)-3,3,3-trifluoro-2-amino-2-methylpropanoic acid + NH3
-
stereospecific reaction
enantiomerically pure product
-
?
(S)-(-)-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide + H2O
(R)-(+)-3,3,3-trifluoro-2-hydroxy-2-methylpropanoic acid + NH3
-
stereospecific reaction
enantiomerically pure product
-
?
(S)-2,2-dimethyl cyclopropanecarboxamide + hydroxylamine
(S)-2,2-dimethylcyclopropane hydroxamic acid + NH3
(S)-2-(3-benzoylphenyl)propanamide + H2O
(S)-2-(3-benzoylphenyl)propanoic acid + NH3
-
ketoprofen amide, R-amide is not converted
ketoprofen
-
?
(S)-2-phenylpropionamide + H2O
(S)-2-phenylpropionate + NH3
no activity with (R)-2-phenylpropionamide
-
-
?
(S)-ibuprofen amide + H2O
(S)-ibuprofen + NH3
-
-
-
-
?
(S)-lactamide + H2O
lactate + NH3
1-naphthalene-acetamide + H2O
1-naphthaleneacetic acid + NH3
-
about 60% of the activity with indole-3-acetamide
-
-
?
1-naphthaleneacetamide + H2O
1-naphthaleneacetic acid + NH3
-
-
-
?
2 indole-3-acetonitrile + 3 H2O
indole-3-acetamide + indole-3-acetic acid + NH3
-
-
-
?
2',6'-dimethylacetanilide + H2O
2,6-dimethylaniline + acetate
-
-
-
?
2,2-dimethylcyclopropanecarboxamide + H2O
(R)-2,2-dimethylcyclopropanecarboxylic acid + NH3
2-aminobenzamide + H2O
2-aminobenzoic acid + NH3
2-arachidonoylglycerol + H2O
?
2-arachidonoylglycerol + H2O
arachidonic acid + glycerol
2-arylpropionic amide + H2O
(S)-2-arylpropionic acid + NH3
2-chloroacetamide + H2O
2-chloroacetate + NH3
-
-
-
-
?
2-chloropropionamide + H2O
2-chloropropionate + NH3
2-hydroxybenzamide + H2O
2-hydroxybenzoic acid + NH3
2-nitroacetanilide
2-nitrophenylamine + acetate
2-thiophenecarboxamide + H2O
2-thiophenecarboxylate + NH3
-
-
-
?
2-toluamide + H2O
2-toluic acid + NH3
2-tolylamide + H2O
? + NH3
-
-
-
-
?
3',4'-dichloropropionanilide + H2O
3,4-dichloroaniline + propanoate
-
-
-
?
3,3,3-trifluoro-2-hydroxy-2-methylpropanamide + H2O
3,3,3-trifluoro-2-hydroxy-2-methylpropanoic acid + NH3
-
-
-
-
?
3-hydroxymyristoyl lipid A + H2O
?
-
3-hydroxymyristoyl group linked to the proximal glucosamine residue of de-O-acylated lipid A, hydolysis by isozyme FAAI
-
-
?
3-indolacetamide + H2O
3-indolacetate + NH3
-
-
-
?
3-indolylacetamide + H2O
3-indolylacetic acid + NH3
-
-
-
-
?
3-phenyl-propionamide + H2O
3-phenyl-propionate + NH3
-
-
-
-
?
3-phenylpropionamide + H2O
3-phenylpropionate + NH3
3-toluamide + H2O
3-toluic acid + NH3
-
-
-
?
3-tolylamide + H2O
? + NH3
-
-
-
-
?
4'-methylacetanilide + H2O
4-methylaniline + acetate
-
-
-
?
4-aminobenzamide + H2O
4-aminobenzoic acid + NH3
4-chloro-3-hydroxybutyramide + H2O
4-chloro-3-hydroxybutyrate + NH3
-
substrate of the soluble enzyme and of the immobilized, cross-linked enzyme
-
-
?
4-chloro-3-hydroxybutyramide + H2O
4-chloro-3-hydroxybutyric acid + NH3
-
-
-
?
4-guanidinobutyramide + H2O
?
4-hydroxybenzamide + H2O
4-hydroxybenzoate + NH3
-
-
-
?
4-hydroxybenzamide + H2O
4-hydroxybenzoic acid + NH3
4-methylbenzamide + H2O
4-methylbenzoic acid + NH3
4-nitroacetanilide + H2O
4-nitroaniline + acetate
4-nitroacetanilide + H2O
acetic acid + 4-nitroaniline
4-nitrobenzamide + H2O
4-nitrobenzoate + NH3
-
-
-
?
4-nitrophenyl acetate + H2O
4-nitrophenol + acetate
4-toluamide + H2O
4-toluic acid + NH3
4-tolylamide + H2O
? + NH3
-
-
-
-
?
5-[(4-nitrophenyl)amino]-5-oxopentanoic acid + H2O
glutarate + 4-nitroaniline
-
-
-
?
5-[(5-carboxypentanoyl)amino]-2-nitrobenzoic acid + H2O
2-nitrobenzoate + adipate
-
-
-
?
acetamide + H2O
acetate + NH3
acetamide + H2O
acetic acid + NH3
acetamide + hydroxylamine
acetylhydroxamic acid + NH3
acetanilide + H2O
acetate + aniline
acetate-prelabeled chicken histones + H2O
deacetylated chicken histones + acetate
acetohydrazide + H2O
hydrazine + acetate
-
-
-
?
acetohydroxamate + H2O
hydroxylamine + acetate
-
-
-
?
acetylcadaverine + H2O
acetate + cadaverine
acetylputrescine + H2O
acetate + putrescine
acetylspermidine + H2O
acetate + spermidine
acrylamide + H2O
acrylate + NH3
acrylamide + H2O
acrylic acid + NH3
acrylamide + H2O
prop-2-enoic acid + NH3
acrylamide + hydroxylamine
acrylhydroxamic acid + NH3
acrylamide + hydroxylamine
acryloylhydroxamic acid + NH3
-
-
-
-
?
acylamide + H2O
carboxylic acid + NH3
-
-
-
?
adipoamide + H2O
adipic acid + NH3
-
-
-
-
?
adipyl-4-nitro-aniline + H2O
?
-
-
-
?
anandamide + H2O
arachidonic acid + ethanolamine
anthranilamide + H2O
anthranilate + NH3
-
-
-
?
arachidonoyl-ethanolamine + H2O
arachidonic acid + ethanolamine
benzamide
benzoic acid + NH3
Blastobacter sp.
-
-
-
?
benzamide + H2O
benzoate + NH3
benzamide + H2O
benzoic acid + NH3
benzamide + hydroxylamine
benzoylhydroxamic acid + NH3
Boc-Lys(epsilon-acetyl)-(4-methyl-coumaryl-7-amide) + H2O
Boc-Lys-(4-methyl-coumaryl-7-amide) + acetate
butyramide + H2O
butyrate + NH3
butyramide + H2O
butyric acid + NH3
-
-
-
?
butyramide + H2O
n-butyrate + NH3
-
-
-
?
butyramide + hydroxylamine
butyrylhydroxamic acid + NH3
carboxylic acid + hydroxylamine
N-hydroxy-carboxylic acid amide + H2O
carboxylic acid amide + H2O
carboxylic acid + NH3
carboxylic acid amide + hydroxylamine
N-hydroxy-carboxylic acid amide + NH3
carboxylic acid ester + hydroxylamine
N-hydroxy-carboxylic acid amide + alcohol
cinnamamide + H2O
cinnamic acid + NH3
cis-(1S,4R)-N-(4-(hydroxymethyl)cyclopent-2-enyl)acetamide + H2O
cis-(1S,4R)-(4-(hydroxymethyl)cyclopent-2-enyl)amine + acetate
used as enzymatic assay
-
-
?
crotonic acid + NH3
crotonamide + H2O
-
5% of the activity with acetic acid. Reaction with crotonamide is 0.3% of the activity with acetamide
-
-
r
cyanoacetamide + H2O
cyanoacetate + NH3
-
low activity
-
-
?
cyclohexanamide + H2O
cyclohexanoate + NH3
-
-
-
?
cyclohexanoamide + H2O
cyclohexanoic acid + NH3
-
-
-
-
?
D-lactamide + H2O
D-lactate + NH3
-
17% of the activity with acetamide, D-selectivity towards lactamide
-
-
?
D-lactamide + hydroxylamine
?
-
-
-
-
?
D-Val-L-Leu-L-Arg 4-nitroanilide + H2O
D-Val-L-Leu-L-Arg + 4-nitroaniline
-
-
-
-
?
diacetamide + H2O
?
-
14% of the activity with acetamide
-
-
?
DL-lactamide + H2O
DL-lactate + NH3
DL-methioninamide + H2O
DL-methionine + NH3
-
-
-
-
?
DL-tryptophanamide + H2O
DL-tryptophan + NH3
-
-
-
-
?
ethyl acetate + H2O
acetic acid + ethanol
ethyl acetate + H2O
ethanol + acetate
-
-
-
?
ethyl acrylate + H2O
acrylate + ethanol
-
-
-
?
ethyl propionate + H2O
ethanol + propionate
-
-
-
?
fluoroacetamide + H2O
fluoroacetate + NH3
-
165% of the activity with acetamide
-
-
?
formamide + H2O
formate + NH3
glutaramic acid + H2O
glutaric acid + NH3
Blastobacter sp.
-
-
-
?
glutaryl-2-naphthylamine + H2O
?
-
-
-
?
glutaryl-aniline + H2O
?
-
-
-
?
glutaryl-nitro-5-amino benzoic acid + H2O
?
-
-
-
?
hexanamide + H2O
hexanoate + NH3
hexanamide + hydroxylamine
hexanoylhydroxamic acid + NH3
-
-
-
-
?
hexanoamide + H2O
hexanoic acid + NH3
-
-
-
-
?
hydroxylamine + acylamide
acylhydroxamate + NH3
-
acyltransferase activity
-
?
hydroxylamine hydrochloride + H2O
?
ibuprofen amide + H2O
ibuprofen + NH3
-
-
-
-
?
indole-3-acetamide + H2O
indole-3-acetate + NH3
indole-3-acetamide + H2O
indole-3-acetic acid + NH3
isobutyramide + H2O
isobutanoate + NH3
-
16% of the activity with acetamide
-
-
?
isobutyramide + H2O
isobutyrate + NH3
isobutyramide + H2O
isobutyric acid + NH3
isobutyramide + hydroxylamine
isobutyrylhydroxamic acid + NH3
isonicotinamide + H2O
isonicotinate + NH3
isonicotinamide + H2O
isonicotinic acid + NH3
ketoprofen amide
2-(3-benzoylphenyl)propionic acid + NH3
L-alaninamide + H2O
L-Ala + NH3
-
3% of the activity with acetamide
-
-
?
L-alaninamide + hydroxylamine
L-alaninoylhydroxamic acid + NH3
-
-
-
-
?
L-alanineamide + H2O
L-alanine + NH3
-
-
-
-
?
L-alanyl-gamma-D-glutamyl-meso-diaminopimelic acid + H2O
L-alanyl-D-glutamic acid + diaminopimelic acid
-
murein tripeptide
-
-
?
L-asparagine + H2O
L-aspartate + NH3
L-glutamine + H2O
L-glutamate + NH3
L-leucinamide + H2O
L-leucine + NH3
L-leucinamide + hydroxylamine
L-leucinoylhydroxamic acid + NH3
-
-
-
-
?
L-leucineamide + H2O
L-leucine + NH3
-
-
-
-
?
L-methioninamide + hydroxylamine
L-methioninoylhydroxamic acid + NH3
-
-
-
-
?
L-prolinamide + H2O
L-proline + NH3
L-prolinamide + hydroxylamine
L-prolinoylhydroxamic acid + NH3
-
-
-
-
?
L-threoninamide + hydroxylamine
L-threoninoylhydroxamic acid + NH3
-
-
-
-
?
L-valineamide + H2O
L-valine + NH3
-
-
-
-
?
lactamide + H2O
lactate + NH3
malonamide + H2O
malonic acid + NH3
-
-
-
-
?
mandelamide + H2O
mandelic acid + NH3
methacrylamide + H2O
methacrylate + NH3
methacrylamide + H2O
methacrylic acid + NH3
monoamidated dicarboxylate + H2O
dicarboxylate + ammonia
Blastobacter sp.
-
-
-
?
mycothiol bimane + H2O
?
-
-
-
-
?
N-(4-hydroxy-2-methylphenyl)arachidonylamide + H2O
4-amino-3-cresol + arachidonic acid
N-(4-hydroxyphenyl)arachidonylamide + H2O
4-aminophenol + arachidonic acid
-
i.e. AM404
-
-
?
n-butyramide + H2O
n-butyric acid + NH3
-
75% of the activity with acetamide. The activity of the reverse reaction is 2% of the activity with acetic acid
-
-
r
N-lauroylethanolamine + H2O
lauric acid + ethanolamine
-
-
-
-
?
N-methylacetamide + H2O
acetic acid + methaneamine
N-methylacetamide + H2O
methylamine + acetate
-
-
-
?
N-methylpropionamide + H2O
methylamine + propionate
-
-
-
?
N-oleoyl ethanolamine + H2O
oleic acid + ethanolamine
N-oleoyl taurine + H2O
oleic acid + taurine
FAAH-1
-
-
?
N-oleoylethanolamine + H2O
oleic acid + ethanolamine
N-palmitolyl ethanolamine + H2O
palmitic acid + ethanolamine
N-palmitoylethanolamine + H2O
palmitic acid + ethanolamine
nicotinamide + H2O
nicotinate + NH3
nicotinamide + H2O
nicotinic acid + NH3
nicotinamide + hydroxylamine
nicotinoylhydroxamic acid + NH3
-
-
-
-
?
oleamide + H2O
oleic acid + NH3
p-nitroacetanilide + H2O
acetic acid + p-nitroaniline
-
mutant T103I
-
-
?
p-nitroacetanilide + H2O
p-nitroaniline + acetate
p-nitrophenylacetamide + H2O
p-nitrophenylacetic acid + NH3
palmitoylethanolamide + H2O
palmitic acid + ethanolamine
-
-
-
-
?
pentanamide + H2O
pentanoate + NH3
phenetidine + acetate
phenacetin + H2O
phenylacetamide
phenylacetic acid + NH3
phenylacetamide + H2O
phenylacetate + NH3
picolinamide + H2O
picolinate + NH3
-
-
-
?
pivalamide + H2O
pivalate + NH3
Pro-Phe-Arg benzylamide + H2O
Pro-Phe-Arg + benzylamine
-
-
-
-
?
prolinamide + H2O
proline + NH3
-
-
-
-
?
propainamide + H2O
? + NH3
-
high activity
-
-
?
propanamide + H2O
propanoic acid + NH3
propionamide + H2O
propanoate + NH3
-
-
-
-
?
propionamide + H2O
propionate + NH3
propionamide + H2O
propionic acid + NH3
propionamide + hydroxylamine
propionylhydroxamic acid + NH3
propionohydrazide + H2O
hydrazine + propionate
-
-
-
?
propionohydroxamate + H2O
hydroxylamine + propionate
-
-
-
?
pyrazinamide + H2O
? + NH3
-
-
-
-
?
pyrazinamide + H2O
pyrazinate + NH3
pyrazinamide + H2O
pyrazinoic acid + NH3
-
-
-
?
R-lactamide + H2O
lactate + NH3
about 65% of the activity with propionamide
-
-
?
salicylamide + H2O
salicylate + NH3
-
-
-
?
short-chain amides + hydrazine
acid hydrazides + NH3
-
-
-
-
?
succinamic acid + H2O
succinic acid + NH3
Blastobacter sp.
-
-
-
?
succinamide + H2O
succinic acid + NH3
-
-
-
-
?
sulfanilamide + H2O
sulfanilate + NH3
-
-
-
-
?
trimethylacetamide + H2O
trimethylacetic acid + NH3
-
-
-
-
?
urea + H2O
carbamic acid + NH3
urea + H2O
CO2 + 2 NH3
-
reaction of EC 3.5.1.5
-
-
?
valeramide + H2O
valerate + NH3
additional information
?
-
(R)-(+)-2-chloropropionamide + H2O
(+)-2-chloropropionic acid + NH3
-
-
-
?
(R)-(+)-2-chloropropionamide + H2O
(+)-2-chloropropionic acid + NH3
-
-
-
?
(R)-2,2-dimethyl cyclopropanecarboxamide + hydroxylamine
(R)-2,2-dimethylcyclopropane hydroxamic acid + NH3
-
R-stereospecific avtivity
-
-
?
(R)-2,2-dimethyl cyclopropanecarboxamide + hydroxylamine
(R)-2,2-dimethylcyclopropane hydroxamic acid + NH3
-
R-stereospecific avtivity
-
-
?
(R)-2,2-dimethyl cyclopropanecarboxamide + hydroxylamine
(R)-2,2-dimethylcyclopropane hydroxamic acid + NH3
-
R-stereospecific avtivity
-
-
?
(R)-2,2-dimethyl cyclopropanecarboxamide + hydroxylamine
(R)-2,2-dimethylcyclopropane hydroxamic acid + NH3
-
R-stereospecific avtivity
-
-
?
(R)-2-chloromandelamide + H2O
(R)-2-chloromandelic acid + NH3
-
-
-
?
(R)-2-chloromandelamide + H2O
(R)-2-chloromandelic acid + NH3
-
-
-
?
(R,S)-2-phenylpropionamide + H2O
(S)-2-phenylpropionic acid + (R)-2-phenylpropionamide + NH3
-
enantioselective reaction with preference for the S-enantiomer
-
-
?
(R,S)-2-phenylpropionamide + H2O
(S)-2-phenylpropionic acid + (R)-2-phenylpropionamide + NH3
-
enantioselective reaction with preference for the S-enantiomer
-
-
?
(S)-(-)-2-chloropropionamide + H2O
(-)-2-chloropropionic acid + NH3
-
-
-
?
(S)-(-)-2-chloropropionamide + H2O
(-)-2-chloropropionic acid + NH3
-
-
-
?
(S)-2,2-dimethyl cyclopropanecarboxamide + hydroxylamine
(S)-2,2-dimethylcyclopropane hydroxamic acid + NH3
-
S-stereospecific activity
-
-
?
(S)-2,2-dimethyl cyclopropanecarboxamide + hydroxylamine
(S)-2,2-dimethylcyclopropane hydroxamic acid + NH3
-
S-stereospecific activity
-
-
?
(S)-2,2-dimethyl cyclopropanecarboxamide + hydroxylamine
(S)-2,2-dimethylcyclopropane hydroxamic acid + NH3
-
S-stereospecific activity
-
-
?
(S)-2,2-dimethyl cyclopropanecarboxamide + hydroxylamine
(S)-2,2-dimethylcyclopropane hydroxamic acid + NH3
-
S-stereospecific activity
-
-
?
(S)-lactamide + H2O
lactate + NH3
-
-
-
?
(S)-lactamide + H2O
lactate + NH3
about 35% of the activity with propionamide
-
-
?
2,2-dimethylcyclopropanecarboxamide + H2O
(R)-2,2-dimethylcyclopropanecarboxylic acid + NH3
-
70 min of bioconversion at 35°C, kinetic resolution of (R,S)-2,2-dimethylcyclopropanecarboxamide by the amidase affords (S)-2,2-dimethylcyclopropanecarboxamide in 41.1% yield (>99% ee) and (R)-2,2-dimethylcyclopropanecarboxylic acid in 49.9% yield (69.7% ee). The enantioselectivity is temperature dependent and is enhanced from 12.6 at 45°C to 65.9 at 14°C
-
-
?
2,2-dimethylcyclopropanecarboxamide + H2O
(R)-2,2-dimethylcyclopropanecarboxylic acid + NH3
-
70 min of bioconversion at 35°C, kinetic resolution of (R,S)-2,2-dimethylcyclopropanecarboxamide by the amidase affords (S)-2,2-dimethylcyclopropanecarboxamide in 41.1% yield (>99% ee) and (R)-2,2-dimethylcyclopropanecarboxylic acid in 49.9% yield (69.7% ee). The enantioselectivity is temperature dependent and is enhanced from 12.6 at 45°C to 65.9 at 14°C
-
-
?
2-aminobenzamide + H2O
2-aminobenzoic acid + NH3
-
-
-
-
?
2-aminobenzamide + H2O
2-aminobenzoic acid + NH3
-
-
-
?
2-arachidonoylglycerol + H2O
?
-
-
-
?
2-arachidonoylglycerol + H2O
?
-
-
-
?
2-arachidonoylglycerol + H2O
arachidonic acid + glycerol
-
-
-
?
2-arachidonoylglycerol + H2O
arachidonic acid + glycerol
-
-
-
?
2-arylpropionic amide + H2O
(S)-2-arylpropionic acid + NH3
-
enantioselective S-amidase
-
?
2-arylpropionic amide + H2O
(S)-2-arylpropionic acid + NH3
-
enantioselective S-amidase
-
?
2-chloropropionamide + H2O
2-chloropropionate + NH3
-
-
-
?
2-chloropropionamide + H2O
2-chloropropionate + NH3
-
-
-
?
2-hydroxybenzamide + H2O
2-hydroxybenzoic acid + NH3
-
-
-
-
?
2-hydroxybenzamide + H2O
2-hydroxybenzoic acid + NH3
-
-
-
?
2-nitroacetanilide
2-nitrophenylamine + acetate
-
-
-
?
2-nitroacetanilide
2-nitrophenylamine + acetate
-
-
-
?
2-toluamide + H2O
2-toluic acid + NH3
-
-
-
-
?
2-toluamide + H2O
2-toluic acid + NH3
-
-
-
?
2-toluamide + H2O
2-toluic acid + NH3
-
-
-
-
?
3-phenylpropionamide + H2O
3-phenylpropionate + NH3
-
-
-
?
3-phenylpropionamide + H2O
3-phenylpropionate + NH3
-
-
-
-
?
4-aminobenzamide + H2O
4-aminobenzoic acid + NH3
-
-
-
-
?
4-aminobenzamide + H2O
4-aminobenzoic acid + NH3
-
-
-
?
4-guanidinobutyramide + H2O
?
best substrate
-
-
?
4-guanidinobutyramide + H2O
?
probably the natural substrate
-
-
?
4-hydroxybenzamide + H2O
4-hydroxybenzoic acid + NH3
-
-
-
-
?
4-hydroxybenzamide + H2O
4-hydroxybenzoic acid + NH3
-
-
-
?
4-methylbenzamide + H2O
4-methylbenzoic acid + NH3
-
-
-
-
?
4-methylbenzamide + H2O
4-methylbenzoic acid + NH3
-
-
-
?
4-methylbenzamide + H2O
4-methylbenzoic acid + NH3
best aromatic substrate
-
-
?
4-nitroacetanilide + H2O
4-nitroaniline + acetate
-
-
-
-
?
4-nitroacetanilide + H2O
4-nitroaniline + acetate
-
-
-
-
?
4-nitroacetanilide + H2O
acetic acid + 4-nitroaniline
-
-
-
-
?
4-nitroacetanilide + H2O
acetic acid + 4-nitroaniline
-
-
-
-
?
4-nitrophenyl acetate + H2O
4-nitrophenol + acetate
-
-
-
?
4-nitrophenyl acetate + H2O
4-nitrophenol + acetate
-
-
-
?
4-toluamide + H2O
4-toluic acid + NH3
-
-
-
?
4-toluamide + H2O
4-toluic acid + NH3
-
-
-
-
?
acetamide + H2O
?
-
-
-
?
acetamide + H2O
?
-
-
-
?
acetamide + H2O
acetate + NH3
-
-
-
-
?
acetamide + H2O
acetate + NH3
-
high activity
-
-
?
acetamide + H2O
acetate + NH3
-
high activity
-
-
?
acetamide + H2O
acetate + NH3
-
-
-
-
?
acetamide + H2O
acetate + NH3
-
-
-
-
?
acetamide + H2O
acetate + NH3
-
-
-
-
?
acetamide + H2O
acetate + NH3
-
-
-
-
?
acetamide + H2O
acetate + NH3
-
-
-
-
?
acetamide + H2O
acetate + NH3
-
-
-
-
?
acetamide + H2O
acetate + NH3
-
best substrate
-
-
?
acetamide + H2O
acetate + NH3
-
-
-
-
?
acetamide + H2O
acetate + NH3
-
best substrate
-
-
?
acetamide + H2O
acetate + NH3
-
-
-
-
?
acetamide + H2O
acetate + NH3
about 10% of the activity with propionamide
-
-
?
acetamide + H2O
acetate + NH3
about 25% of the activity with (S)-lactamide
-
-
?
acetamide + H2O
acetate + NH3
-
-
-
?
acetamide + H2O
acetate + NH3
-
-
-
-
?
acetamide + H2O
acetate + NH3
-
-
-
-
?
acetamide + H2O
acetate + NH3
-
-
-
-
?
acetamide + H2O
acetate + NH3
-
-
-
-
?
acetamide + H2O
acetate + NH3
-
-
-
?
acetamide + H2O
acetate + NH3
-
-
-
-
?
acetamide + H2O
acetate + NH3
-
substrate of the soluble enzyme and of the immobilized, cross-linked enzyme, low activity
-
-
?
acetamide + H2O
acetate + NH3
-
-
-
-
?
acetamide + H2O
acetate + NH3
-
-
-
-
?
acetamide + H2O
acetate + NH3
-
-
-
?
acetamide + H2O
acetate + NH3
-
-
-
-
?
acetamide + H2O
acetate + NH3
-
-
-
-
?
acetamide + H2O
acetate + NH3
-
-
-
?
acetamide + H2O
acetate + NH3
-
-
-
?
acetamide + H2O
acetic acid + NH3
-
-
-
-
?
acetamide + H2O
acetic acid + NH3
-
-
-
?
acetamide + H2O
acetic acid + NH3
-
-
-
-
?
acetamide + H2O
acetic acid + NH3
-
mutant W138G and T103I
-
-
?
acetamide + H2O
acetic acid + NH3
-
-
-
-
?
acetamide + H2O
acetic acid + NH3
-
-
-
-
?
acetamide + H2O
acetic acid + NH3
-
-
-
-
?
acetamide + H2O
acetic acid + NH3
also acyl transfer activity in the presence of hydroxylamine
-
-
?
acetamide + H2O
acetic acid + NH3
also acyl transfer activity in the presence of hydroxylamine
-
-
?
acetamide + H2O
acetic acid + NH3
-
amidase-catalyzed amide formation may cause the remaining of acetamide in the acetonitrile conversion process
-
-
r
acetamide + H2O
acetic acid + NH3
-
amidase-catalyzed amide formation may cause the remaining of acetamide in the acetonitrile conversion process
-
-
r
acetamide + H2O
acetic acid + NH3
-
-
-
?
acetamide + H2O
acetic acid + NH3
-
-
-
?
acetamide + hydroxylamine
acetylhydroxamic acid + NH3
-
-
-
-
?
acetamide + hydroxylamine
acetylhydroxamic acid + NH3
-
Ping Pong Bi Bi type mechanism
-
-
?
acetamide + hydroxylamine
acetylhydroxamic acid + NH3
-
Ping Pong Bi Bi type mechanism
-
-
?
acetanilide + H2O
acetate + aniline
-
-
-
-
?
acetanilide + H2O
acetate + aniline
-
-
-
-
?
acetanilide + H2O
acetate + aniline
-
-
-
?
acetanilide + H2O
acetate + aniline
-
-
-
?
acetate-prelabeled chicken histones + H2O
deacetylated chicken histones + acetate
-
-
-
?
acetate-prelabeled chicken histones + H2O
deacetylated chicken histones + acetate
-
-
-
?
acetylcadaverine + H2O
acetate + cadaverine
-
-
-
?
acetylcadaverine + H2O
acetate + cadaverine
-
-
-
?
acetylputrescine + H2O
acetate + putrescine
-
-
-
?
acetylputrescine + H2O
acetate + putrescine
-
-
-
?
acetylspermidine + H2O
acetate + spermidine
-
-
-
?
acetylspermidine + H2O
acetate + spermidine
-
-
-
?
acrylamide + H2O
acrylate + NH3
-
-
-
-
?
acrylamide + H2O
acrylate + NH3
-
102% of the activity with acetamide
-
-
?
acrylamide + H2O
acrylate + NH3
-
-
-
-
?
acrylamide + H2O
acrylate + NH3
-
-
-
-
?
acrylamide + H2O
acrylate + NH3
-
-
-
-
?
acrylamide + H2O
acrylate + NH3
-
best substrate
-
-
?
acrylamide + H2O
acrylate + NH3
-
-
-
-
?
acrylamide + H2O
acrylate + NH3
-
-
-
-
?
acrylamide + H2O
acrylate + NH3
-
-
-
-
?
acrylamide + H2O
acrylate + NH3
-
-
-
-
?
acrylamide + H2O
acrylate + NH3
-
-
-
?
acrylamide + H2O
acrylate + NH3
-
-
-
-
?
acrylamide + H2O
acrylate + NH3
-
substrate of the soluble enzyme and of the immobilized, cross-linked enzyme
-
-
?
acrylamide + H2O
acrylate + NH3
-
-
-
-
?
acrylamide + H2O
acrylate + NH3
low activity
-
-
?
acrylamide + H2O
acrylate + NH3
-
-
-
?
acrylamide + H2O
acrylic acid + NH3
-
-
-
-
?
acrylamide + H2O
acrylic acid + NH3
-
-
-
?
acrylamide + H2O
acrylic acid + NH3
-
-
-
?
acrylamide + H2O
acrylic acid + NH3
also acyl transfer activity in the presence of hydroxylamine
-
-
?
acrylamide + H2O
acrylic acid + NH3
also acyl transfer activity in the presence of hydroxylamine
-
-
?
acrylamide + H2O
acrylic acid + NH3
-
-
-
?
acrylamide + H2O
acrylic acid + NH3
-
42% of the activity with acetamide. The activity of the reverse reaction is 3% of the activity with acetic acid
-
-
r
acrylamide + H2O
acrylic acid + NH3
-
42% of the activity with acetamide. The activity of the reverse reaction is 3% of the activity with acetic acid
-
-
r
acrylamide + H2O
prop-2-enoic acid + NH3
-
-
-
-
?
acrylamide + H2O
prop-2-enoic acid + NH3
-
mutant W138G
-
-
?
acrylamide + hydroxylamine
acrylhydroxamic acid + NH3
-
-
-
-
?
acrylamide + hydroxylamine
acrylhydroxamic acid + NH3
-
-
-
-
?
anandamide + H2O
?
-
-
-
-
?
anandamide + H2O
?
-
i.e. arachidonoylethanolamide
-
-
?
anandamide + H2O
?
-
i.e. arachidonoylethanolamide or AEA
-
-
?
anandamide + H2O
?
-
i.e. arachidonoylethanolamide
-
-
?
anandamide + H2O
?
-
i.e. arachidonoylethanolamide or AEA
-
-
?
anandamide + H2O
arachidonic acid + ethanolamine
FAAH-1
-
-
?
anandamide + H2O
arachidonic acid + ethanolamine
FAAH-2
-
-
?
anandamide + H2O
arachidonic acid + ethanolamine
substrates in order of decreasing activity: anandamide, N-oleoylethanolamine, N-palmitoylethanolamine
-
-
?
anandamide + H2O
arachidonic acid + ethanolamine
substrates in order of decreasing activity: N-palmitoylethanolamine, N-oleoylethanolamine, anandamide
-
-
?
anandamide + H2O
arachidonic acid + ethanolamine
substrates in order of decreasing activity: anandamide, N-oleoylethanolamine, N-palmitoylethanolamine
-
-
?
anandamide + H2O
arachidonic acid + ethanolamine
substrates in order of decreasing activity: N-palmitoylethanolamine, N-oleoylethanolamine, anandamide
-
-
?
anandamide + H2O
arachidonic acid + ethanolamine
-
-
-
-
?
anandamide + H2O
arachidonic acid + ethanolamine
substrates in order of decreasing activity: anandamide, N-oleoylethanolamine, N-palmitoylethanolamine
-
-
?
anandamide + H2O
arachidonic acid + ethanolamine
substrates in order of decreasing activity: N-palmitoylethanolamine, N-oleoylethanolamine, anandamide
-
-
?
anandamide + H2O
arachidonic acid + ethanolamine
substrates in order of decreasing activity: anandamide, N-oleoylethanolamine, N-palmitoylethanolamine
-
-
?
arachidonoyl-ethanolamine + H2O
arachidonic acid + ethanolamine
-
hydrolysis of anandamide
-
-
?
arachidonoyl-ethanolamine + H2O
arachidonic acid + ethanolamine
-
hydrolysis of anandamide
-
-
?
benzamide + H2O
benzoate + NH3
-
-
-
-
?
benzamide + H2O
benzoate + NH3
-
-
-
-
?
benzamide + H2O
benzoate + NH3
-
-
-
?
benzamide + H2O
benzoate + NH3
-
-
-
-
?
benzamide + H2O
benzoate + NH3
-
substrate of the soluble enzyme and of the immobilized, cross-linked enzyme
-
-
?
benzamide + H2O
benzoate + NH3
-
-
-
-
?
benzamide + H2O
benzoate + NH3
preferred substrate
-
-
?
benzamide + H2O
benzoate + NH3
-
-
-
-
?
benzamide + H2O
benzoate + NH3
-
-
-
?
benzamide + H2O
benzoate + NH3
-
-
-
-
?
benzamide + H2O
benzoate + NH3
-
-
-
?
benzamide + H2O
benzoate + NH3
-
-
-
?
benzamide + H2O
benzoate + NH3
-
-
-
?
benzamide + H2O
benzoic acid + NH3
-
-
-
?
benzamide + H2O
benzoic acid + NH3
-
-
-
-
?
benzamide + H2O
benzoic acid + NH3
-
-
-
?
benzamide + H2O
benzoic acid + NH3
-
-
-
-
?
benzamide + H2O
benzoic acid + NH3
-
-
-
-
?
benzamide + H2O
benzoic acid + NH3
also acyl transfer activity in the presence of hydroxylamine
-
-
?
benzamide + H2O
benzoic acid + NH3
also acyl transfer activity in the presence of hydroxylamine
-
-
?
benzamide + H2O
benzoic acid + NH3
-
-
-
-
?
benzamide + H2O
benzoic acid + NH3
-
-
-
-
?
benzamide + H2O
benzoic acid + NH3
-
-
-
-
?
benzamide + hydroxylamine
benzoylhydroxamic acid + NH3
-
-
-
-
?
benzamide + hydroxylamine
benzoylhydroxamic acid + NH3
-
-
-
-
?
Boc-Lys(epsilon-acetyl)-(4-methyl-coumaryl-7-amide) + H2O
Boc-Lys-(4-methyl-coumaryl-7-amide) + acetate
-
-
-
?
Boc-Lys(epsilon-acetyl)-(4-methyl-coumaryl-7-amide) + H2O
Boc-Lys-(4-methyl-coumaryl-7-amide) + acetate
-
-
-
?
butyramide + H2O
butyrate + NH3
-
-
-
-
?
butyramide + H2O
butyrate + NH3
-
high activity
-
-
?
butyramide + H2O
butyrate + NH3
-
substrate of the soluble enzyme and of the immobilized, cross-linked enzyme
-
-
?
butyramide + H2O
butyrate + NH3
-
-
-
-
?
butyramide + H2O
butyrate + NH3
-
-
-
?
butyramide + H2O
butyrate + NH3
-
-
-
-
?
butyramide + H2O
butyrate + NH3
-
-
-
?
butyramide + hydroxylamine
butyrylhydroxamic acid + NH3
-
-
-
-
?
butyramide + hydroxylamine
butyrylhydroxamic acid + NH3
-
-
-
-
?
carboxylic acid + hydroxylamine
N-hydroxy-carboxylic acid amide + H2O
-
acid transferase transferase activity
-
?
carboxylic acid + hydroxylamine
N-hydroxy-carboxylic acid amide + H2O
-
acid transferase transferase activity
-
?
carboxylic acid amide + H2O
carboxylic acid + NH3
-
-
-
?
carboxylic acid amide + H2O
carboxylic acid + NH3
-
-
-
?
carboxylic acid amide + hydroxylamine
N-hydroxy-carboxylic acid amide + NH3
-
amide transferase activity
-
?
carboxylic acid amide + hydroxylamine
N-hydroxy-carboxylic acid amide + NH3
-
amide transferase activity
-
?
carboxylic acid ester + hydroxylamine
N-hydroxy-carboxylic acid amide + alcohol
-
ester transferase activity
-
?
carboxylic acid ester + hydroxylamine
N-hydroxy-carboxylic acid amide + alcohol
-
ester transferase activity
-
?
cinnamamide + H2O
cinnamic acid + NH3
-
-
-
?
cinnamamide + H2O
cinnamic acid + NH3
-
-
-
?
DL-lactamide + H2O
DL-lactate + NH3
-
-
-
?
DL-lactamide + H2O
DL-lactate + NH3
-
-
-
?
DL-lactamide + H2O
DL-lactate + NH3
-
-
-
-
?
ethyl acetate + H2O
acetic acid + ethanol
-
-
-
-
?
ethyl acetate + H2O
acetic acid + ethanol
-
-
-
-
?
formamide + H2O
formate + NH3
-
-
-
-
?
formamide + H2O
formate + NH3
-
30% of the activity with acetamide
-
-
?
formamide + H2O
formate + NH3
-
-
-
-
?
formamide + H2O
formate + NH3
-
30% of the activity with acetamide
-
-
?
formamide + H2O
formate + NH3
-
-
-
-
?
formamide + H2O
formate + NH3
-
-
-
-
?
formamide + H2O
formate + NH3
-
-
-
-
?
formamide + H2O
formate + NH3
22.5% of the activity with acetamide
-
-
?
formamide + H2O
formate + NH3
22.5% of the activity with acetamide
-
-
?
formamide + H2O
formate + NH3
-
99% of the activity with acetamide
-
-
?
formamide + H2O
formate + NH3
-
99% of the activity with acetamide
-
-
?
hexanamide + H2O
hexanoate + NH3
-
-
-
-
?
hexanamide + H2O
hexanoate + NH3
38.7% of the activity with acetamide
-
-
?
hexanamide + H2O
hexanoate + NH3
-
-
-
?
hexanamide + H2O
hexanoate + NH3
-
-
-
-
?
hydroxylamine hydrochloride + H2O
?
-
-
-
-
?
hydroxylamine hydrochloride + H2O
?
-
-
-
?
hydroxylamine hydrochloride + H2O
?
-
-
-
?
indole-3-acetamide + H2O
indole-3-acetate + NH3
-
-
-
-
?
indole-3-acetamide + H2O
indole-3-acetate + NH3
-
-
-
-
?
indole-3-acetamide + H2O
indole-3-acetate + NH3
-
-
-
?
indole-3-acetamide + H2O
indole-3-acetic acid + NH3
-
-
-
-
?
indole-3-acetamide + H2O
indole-3-acetic acid + NH3
-
role of amidase 1 in auxin biosynthesis. Amidase 1 may be involved in de novo synthesis of indole-3-acetic acid in Arabidopsis thaliana
-
-
?
indole-3-acetamide + H2O
indole-3-acetic acid + NH3
-
-
-
?
isobutyramide + H2O
isobutyrate + NH3
-
-
-
-
?
isobutyramide + H2O
isobutyrate + NH3
-
-
-
-
?
isobutyramide + H2O
isobutyrate + NH3
-
high activity
-
-
?
isobutyramide + H2O
isobutyrate + NH3
-
high activity
-
-
?
isobutyramide + H2O
isobutyrate + NH3
-
substrate of the soluble enzyme and of the immobilized, cross-linked enzyme, preferred substrate
-
-
?
isobutyramide + H2O
isobutyrate + NH3
-
-
-
?
isobutyramide + H2O
isobutyrate + NH3
-
-
-
-
?
isobutyramide + H2O
isobutyrate + NH3
-
-
-
?
isobutyramide + H2O
isobutyrate + NH3
-
-
-
-
?
isobutyramide + H2O
isobutyrate + NH3
best aliphatic substrate
-
-
?
isobutyramide + H2O
isobutyrate + NH3
best aliphatic substrate
-
-
?
isobutyramide + H2O
isobutyrate + NH3
-
-
-
?
isobutyramide + H2O
isobutyrate + NH3
-
-
-
?
isobutyramide + H2O
isobutyric acid + NH3
-
-
-
-
?
isobutyramide + H2O
isobutyric acid + NH3
-
-
-
?
isobutyramide + hydroxylamine
isobutyrylhydroxamic acid + NH3
-
-
-
-
?
isobutyramide + hydroxylamine
isobutyrylhydroxamic acid + NH3
-
-
-
-
?
isonicotinamide + H2O
isonicotinate + NH3
-
-
-
-
?
isonicotinamide + H2O
isonicotinate + NH3
-
-
-
?
isonicotinamide + H2O
isonicotinic acid + NH3
-
-
-
-
?
isonicotinamide + H2O
isonicotinic acid + NH3
-
-
-
?
ketoprofen amide
2-(3-benzoylphenyl)propionic acid + NH3
-
-
-
?
ketoprofen amide
2-(3-benzoylphenyl)propionic acid + NH3
-
-
-
?
L-asparagine + H2O
L-aspartate + NH3
4.8% of the activity with acetamide
-
-
?
L-asparagine + H2O
L-aspartate + NH3
4.8% of the activity with acetamide
-
-
?
L-asparagine + H2O
L-aspartate + NH3
-
-
-
?
L-asparagine + H2O
L-aspartate + NH3
-
-
-
?
L-glutamine + H2O
L-glutamate + NH3
73% of the activity with acetamide
-
-
?
L-glutamine + H2O
L-glutamate + NH3
73% of the activity with acetamide
-
-
?
L-glutamine + H2O
L-glutamate + NH3
-
-
-
?
L-glutamine + H2O
L-glutamate + NH3
-
-
-
?
L-leucinamide + H2O
L-leucine + NH3
-
-
-
-
?
L-leucinamide + H2O
L-leucine + NH3
-
-
-
-
?
L-prolinamide + H2O
L-proline + NH3
-
-
-
-
?
L-prolinamide + H2O
L-proline + NH3
-
-
-
?
lactamide + H2O
lactate + NH3
-
-
-
-
?
lactamide + H2O
lactate + NH3
-
-
-
-
?
lactamide + H2O
lactate + NH3
-
-
-
?
mandelamide + H2O
mandelic acid + NH3
-
-
-
?
mandelamide + H2O
mandelic acid + NH3
-
-
-
?
methacrylamide + H2O
methacrylate + NH3
-
-
-
-
?
methacrylamide + H2O
methacrylate + NH3
-
-
-
-
?
methacrylamide + H2O
methacrylate + NH3
-
-
-
?
methacrylamide + H2O
methacrylate + NH3
-
-
-
-
?
methacrylamide + H2O
methacrylic acid + NH3
-
-
-
-
?
methacrylamide + H2O
methacrylic acid + NH3
-
17% of the activity with acetamide. The activity of the reverse reaction is 0.1% of the activity with acetic acid
-
-
?
N-(4-hydroxy-2-methylphenyl)arachidonylamide + H2O
4-amino-3-cresol + arachidonic acid
-
i.e. VDM11, 15-20% of the activity with anandamide
-
-
?
N-(4-hydroxy-2-methylphenyl)arachidonylamide + H2O
4-amino-3-cresol + arachidonic acid
-
i.e. VDM11, 15-20% of the activity with anandamide
-
-
?
N-methylacetamide + H2O
acetic acid + methaneamine
-
-
-
-
?
N-methylacetamide + H2O
acetic acid + methaneamine
-
-
-
-
?
N-oleoyl ethanolamine + H2O
oleic acid + ethanolamine
FAAH-1
-
-
?
N-oleoyl ethanolamine + H2O
oleic acid + ethanolamine
FAAH-2
-
-
?
N-oleoylethanolamine + H2O
oleic acid + ethanolamine
substrates in order of decreasing activity: anandamide, N-oleoylethanolamine, N-palmitoylethanolamine
-
-
?
N-oleoylethanolamine + H2O
oleic acid + ethanolamine
substrates in order of decreasing activity: N-palmitoylethanolamine, N-oleoylethanolamine, anandamide
-
-
?
N-oleoylethanolamine + H2O
oleic acid + ethanolamine
substrates in order of decreasing activity: anandamide, N-oleoylethanolamine, N-palmitoylethanolamine
-
-
?
N-oleoylethanolamine + H2O
oleic acid + ethanolamine
substrates in order of decreasing activity: N-palmitoylethanolamine, N-oleoylethanolamine, anandamide
-
-
?
N-oleoylethanolamine + H2O
oleic acid + ethanolamine
substrates in order of decreasing activity: anandamide, N-oleoylethanolamine, N-palmitoylethanolamine
-
-
?
N-oleoylethanolamine + H2O
oleic acid + ethanolamine
substrates in order of decreasing activity: N-palmitoylethanolamine, N-oleoylethanolamine, anandamide
-
-
?
N-oleoylethanolamine + H2O
oleic acid + ethanolamine
substrates in order of decreasing activity: anandamide, N-oleoylethanolamine, N-palmitoylethanolamine
-
-
?
N-palmitolyl ethanolamine + H2O
palmitic acid + ethanolamine
FAAH-1
-
-
?
N-palmitolyl ethanolamine + H2O
palmitic acid + ethanolamine
FAAH-2
-
-
?
N-palmitoylethanolamine + H2O
palmitic acid + ethanolamine
substrates in order of decreasing activity: anandamide, N-oleoylethanolamine, N-palmitoylethanolamine
-
-
?
N-palmitoylethanolamine + H2O
palmitic acid + ethanolamine
substrates in order of decreasing activity: N-palmitoylethanolamine, N-oleoylethanolamine, anandamide
-
-
?
N-palmitoylethanolamine + H2O
palmitic acid + ethanolamine
substrates in order of decreasing activity: anandamide, N-oleoylethanolamine, N-palmitoylethanolamine
-
-
?
N-palmitoylethanolamine + H2O
palmitic acid + ethanolamine
substrates in order of decreasing activity: N-palmitoylethanolamine, N-oleoylethanolamine, anandamide
-
-
?
N-palmitoylethanolamine + H2O
palmitic acid + ethanolamine
substrates in order of decreasing activity: anandamide, N-oleoylethanolamine, N-palmitoylethanolamine
-
-
?
N-palmitoylethanolamine + H2O
palmitic acid + ethanolamine
substrates in order of decreasing activity: N-palmitoylethanolamine, N-oleoylethanolamine, anandamide
-
-
?
N-palmitoylethanolamine + H2O
palmitic acid + ethanolamine
substrates in order of decreasing activity: anandamide, N-oleoylethanolamine, N-palmitoylethanolamine
-
-
?
nicotinamide + H2O
nicotinate + NH3
-
reaction of EC 3.5.1.19, nicotinamidase
-
-
?
nicotinamide + H2O
nicotinate + NH3
low activity, reaction of EC 3.5.1.19
-
-
?
nicotinamide + H2O
nicotinate + NH3
reaction of EC 3.5.1.19, nicotinamidase
-
-
?
nicotinamide + H2O
nicotinic acid + NH3
-
-
-
-
?
nicotinamide + H2O
nicotinic acid + NH3
-
-
-
-
?
nicotinamide + H2O
nicotinic acid + NH3
-
absolute specificity
-
-
?
nicotinamide + H2O
nicotinic acid + NH3
-
-
-
-
?
nicotinamide + H2O
nicotinic acid + NH3
-
-
-
?
nicotinamide + H2O
nicotinic acid + NH3
-
-
-
-
?
nicotinamide + H2O
nicotinic acid + NH3
Torula cremoris
-
absolute specificity
-
-
?
oleamide + H2O
?
-
-
-
-
?
oleamide + H2O
?
-
-
-
-
?
oleamide + H2O
oleic acid + NH3
-
-
-
-
?
oleamide + H2O
oleic acid + NH3
FAAH-1
-
-
?
oleamide + H2O
oleic acid + NH3
FAAH-2
-
-
?
oleamide + H2O
oleic acid + NH3
-
-
-
-
?
p-nitroacetanilide + H2O
p-nitroaniline + acetate
-
-
-
-
?
p-nitroacetanilide + H2O
p-nitroaniline + acetate
-
-
-
?
p-nitrophenylacetamide + H2O
p-nitrophenylacetic acid + NH3
-
-
-
-
?
p-nitrophenylacetamide + H2O
p-nitrophenylacetic acid + NH3
-
mutant W138G and T103I-W138G
-
-
?
pentanamide + H2O
pentanoate + NH3
-
-
-
?
pentanamide + H2O
pentanoate + NH3
-
-
-
-
?
pentanamide + H2O
pentanoate + NH3
-
-
-
?
pentanamide + H2O
pentanoate + NH3
-
-
-
?
phenetidine + acetate
phenacetin + H2O
-
transferase activity
-
?
phenetidine + acetate
phenacetin + H2O
-
transferase activity
-
?
phenylacetamide
phenylacetic acid + NH3
-
-
-
-
?
phenylacetamide
phenylacetic acid + NH3
-
-
-
-
?
phenylacetamide
phenylacetic acid + NH3
-
-
-
?
phenylacetamide
phenylacetic acid + NH3
-
-
-
?
phenylacetamide + H2O
phenylacetate + NH3
-
-
-
?
phenylacetamide + H2O
phenylacetate + NH3
-
mutant W138G and T103I-W138G
-
-
?
pivalamide + H2O
pivalate + NH3
-
-
-
?
pivalamide + H2O
pivalate + NH3
-
-
-
?
propanamide + H2O
propanoic acid + NH3
-
-
-
?
propanamide + H2O
propanoic acid + NH3
-
-
-
?
propionamide + H2O
propionate + NH3
-
best substrate
-
-
?
propionamide + H2O
propionate + NH3
-
67% of the activity with acetamide
-
-
?
propionamide + H2O
propionate + NH3
-
best substrate
-
-
?
propionamide + H2O
propionate + NH3
-
-
-
-
?
propionamide + H2O
propionate + NH3
-
-
-
-
?
propionamide + H2O
propionate + NH3
-
-
-
-
?
propionamide + H2O
propionate + NH3
-
-
-
-
?
propionamide + H2O
propionate + NH3
-
-
-
-
?
propionamide + H2O
propionate + NH3
-
best substrate
-
-
?
propionamide + H2O
propionate + NH3
-
-
-
?
propionamide + H2O
propionate + NH3
-
-
-
-
?
propionamide + H2O
propionate + NH3
-
-
-
-
?
propionamide + H2O
propionate + NH3
-
substrate of the soluble enzyme and of the immobilized, cross-linked enzyme
-
-
?
propionamide + H2O
propionate + NH3
-
-
-
-
?
propionamide + H2O
propionate + NH3
-
-
-
-
?
propionamide + H2O
propionate + NH3
-
-
-
?
propionamide + H2O
propionate + NH3
-
-
-
-
?
propionamide + H2O
propionate + NH3
-
-
-
?
propionamide + H2O
propionate + NH3
-
-
-
-
?
propionamide + H2O
propionate + NH3
-
-
-
?
propionamide + H2O
propionate + NH3
-
-
-
?
propionamide + H2O
propionic acid + NH3
-
-
-
-
?
propionamide + H2O
propionic acid + NH3
-
-
-
?
propionamide + H2O
propionic acid + NH3
about 50% of the activity with (S)-lactamide
-
-
?
propionamide + H2O
propionic acid + NH3
-
-
-
?
propionamide + H2O
propionic acid + NH3
-
-
-
?
propionamide + H2O
propionic acid + NH3
-
-
-
-
?
propionamide + H2O
propionic acid + NH3
also acyl transfer activity in the presence of hydroxylamine
-
-
?
propionamide + H2O
propionic acid + NH3
also acyl transfer activity in the presence of hydroxylamine
-
-
?
propionamide + H2O
propionic acid + NH3
-
79% of the activity with acetamide. The activity of the reverse reaction is 3% of the activity with acetic acid
-
-
r
propionamide + H2O
propionic acid + NH3
-
79% of the activity with acetamide. The activity of the reverse reaction is 3% of the activity with acetic acid
-
-
r
propionamide + H2O
propionic acid + NH3
-
-
-
?
propionamide + H2O
propionic acid + NH3
-
-
-
?
propionamide + hydroxylamine
propionylhydroxamic acid + NH3
-
-
-
-
?
propionamide + hydroxylamine
propionylhydroxamic acid + NH3
-
-
-
-
?
pyrazinamide + H2O
pyrazinate + NH3
low activity
-
-
?
pyrazinamide + H2O
pyrazinate + NH3
-
-
-
?
RCONH2 + H2O
RCOOH + NH3
-
-
-
?
RCONH2 + H2O
RCOOH + NH3
-
-
-
?
RCONH2 + H2O
RCOOH + NH3
-
-
-
?
RCONH2 + H2O
RCOOH + NH3
-
-
-
?
RCONH2 + H2O
RCOOH + NH3
-
-
-
?
RCONH2 + H2O
RCOOH + NH3
-
-
-
?
RCONH2 + H2O
RCOOH + NH3
-
-
-
?
RCONH2 + H2O
RCOOH + NH3
-
-
-
?
RCONH2 + H2O
RCOOH + NH3
-
-
-
?
urea + H2O
?
-
1.5% of the activity with acetamide
-
-
?
urea + H2O
?
-
1.5% of the activity with acetamide
-
-
?
urea + H2O
carbamic acid + NH3
-
-
-
-
?
urea + H2O
carbamic acid + NH3
-
-
-
-
?
valeramide + H2O
valerate + NH3
-
-
-
?
valeramide + H2O
valerate + NH3
-
-
-
?
valeramide + H2O
valerate + NH3
-
high activity
-
-
?
valeramide + H2O
valerate + NH3
-
high activity
-
-
?
additional information
?
-
substrate specificity towards cephalosporin analogues, overview, no activity with cephalosporin C
-
-
?
additional information
?
-
-
substrate specificity towards cephalosporin analogues, overview, no activity with cephalosporin C
-
-
?
additional information
?
-
-
acyl transfer reactions are demonstrated with acetamide, propionamide, isobutyramide, and acrylamide as substrates and hydroxylamine as the acyl acceptor. The highest reaction rate being with isobutyramide. Immobilization by entrapment in polyacrylamide gels, covalent binding on Eupergit C beads at 4°C and on Amberlite-XAD57 results in low protein binding and low activity, but immobilization on Eupergit C beads at 25°C with cross-linking resulted in high protein binding yield and high immobilized specific activity. No activity with: nicotinamide, isonicotinamide, L-asparagine, D-asparagine, DL-phenylalanine, L-prolinamide, hexanamide
-
-
?
additional information
?
-
-
not active on L-lactamide
-
-
?
additional information
?
-
-
the enzyme preferentially hydrolyzes small aliphatic amides and has a narrow substrate spectrum, overview. Poor activity with methacrylamide, N-methyl acetamide, cyanoacetamide, and butyramide. No activity with thioacetamide, trimethylacetamide, N-ethylacetamide, dimethylformamide, nicotinamide, and benzamide
-
-
?
additional information
?
-
-
the enzyme preferentially hydrolyzes small aliphatic amides and has a narrow substrate spectrum, overview. Poor activity with methacrylamide, N-methyl acetamide, cyanoacetamide, and butyramide. No activity with thioacetamide, trimethylacetamide, N-ethylacetamide, dimethylformamide, nicotinamide, and benzamide
-
-
?
additional information
?
-
-
acyl transfer reactions are demonstrated with acetamide, propionamide, isobutyramide, and acrylamide as substrates and hydroxylamine as the acyl acceptor. The highest reaction rate being with isobutyramide. Immobilization by entrapment in polyacrylamide gels, covalent binding on Eupergit C beads at 4°C and on Amberlite-XAD57 results in low protein binding and low activity, but immobilization on Eupergit C beads at 25°C with cross-linking resulted in high protein binding yield and high immobilized specific activity. No activity with: nicotinamide, isonicotinamide, L-asparagine, D-asparagine, DL-phenylalanine, L-prolinamide, hexanamide
-
-
?
additional information
?
-
-
not active on L-lactamide
-
-
?
additional information
?
-
-
the amidase of the organism exhibits dual activity i.e. hydrolase as well as acyl transfer. The acyl transfer activity of amidase forms an hydroxamate and ammonia from an amide and hydroxylamine and shows broader substrate affinity ranging from a variety of aliphatic amides (formamide, acetamide, propanamide etc.) to aromatic amides (benzamide, mandelamide, nicotinamide etc.) along with hydroxylamine for the biotransformation of these amides into corresponding hydroxamic acid, substrate specificity, overview
-
-
?
additional information
?
-
-
the amidase of the organism exhibits dual activity i.e. hydrolase as well as acyl transfer. The acyl transfer activity of amidase forms an hydroxamate and ammonia from an amide and hydroxylamine and shows broader substrate affinity ranging from a variety of aliphatic amides (formamide, acetamide, propanamide etc.) to aromatic amides (benzamide, mandelamide, nicotinamide etc.) along with hydroxylamine for the biotransformation of these amides into corresponding hydroxamic acid, substrate specificity, overview
-
-
?
additional information
?
-
-
AtFAAH is one, but not the only, modulator of endogenous N-acylethanolamine levels in plants (N-acylethanolamine depletion likely participates in the regulation of plant growth)
-
-
?
additional information
?
-
-
N-acylethanolamines and oleamide are not hydrolyzed signifiantly
-
-
?
additional information
?
-
-
no activity with methacrylamide and nicotinamide
-
-
?
additional information
?
-
-
methacrylamide and nicotinamide are no substrates
-
-
?
additional information
?
-
-
no activity with methacrylamide and nicotinamide
-
-
?
additional information
?
-
-
methacrylamide and nicotinamide are no substrates
-
-
?
additional information
?
-
-
amidation of the C-terminal carboxylic group of several N-protected di-, tri-, tetra and pentapeptides
-
-
?
additional information
?
-
-
the enzyme is specific for cleavage of the gamma-D-glutamyl-meso-diaminopimelic acid bond of free murein tripeptide but not of peptides linked to muramic acid
-
-
?
additional information
?
-
-
glycinamide, malonamide, acetamide, and acrylamide are poor substrates, while urea, mandelamide, N-methylacetamide, and thioacetamide are no substrates, substrate specificity, overview
-
-
?
additional information
?
-
-
glycinamide, malonamide, acetamide, and acrylamide are poor substrates, while urea, mandelamide, N-methylacetamide, and thioacetamide are no substrates, substrate specificity, overview
-
-
?
additional information
?
-
-
the human tissue kallikrein shows amidase activity, the enzyme hydrolyzes various synthetic substrates such as Nalpha-substituted arginine and lysine derivatives as esters, amides and fluorogenic peptides, overview
-
-
?
additional information
?
-
FAAH-1 plays a primary role in regulating endocannabinoid signaling
-
-
?
additional information
?
-
FAAH-1 plays a primary role in regulating endocannabinoid signaling
-
-
?
additional information
?
-
-
FAAH-1 plays a primary role in regulating endocannabinoid signaling
-
-
?
additional information
?
-
hardly hydrolyzes 2-arachidonoylglycerol
-
-
?
additional information
?
-
hardly hydrolyzes 2-arachidonoylglycerol
-
-
?
additional information
?
-
-
hardly hydrolyzes 2-arachidonoylglycerol
-
-
?
additional information
?
-
no FAAH-2 activity is detected with N-oleoyl taurine
-
-
?
additional information
?
-
no FAAH-2 activity is detected with N-oleoyl taurine
-
-
?
additional information
?
-
-
no FAAH-2 activity is detected with N-oleoyl taurine
-
-
?
additional information
?
-
-
the Fv dimer was constructed by using the crystallographic structure of antibody 25.3, PDB 1AFV, as a template, activity of the amide hydrolyzing antibody 312D6 with sulfonamide hapten substrates, complex formation and structure, antibody 312d6 is highly specific for p-tolylsubstituted indole sulfonamides and carboxamides, docking analysis, overview
-
-
?
additional information
?
-
-
substrate synthesis, overview, substrate specificity of the stereospecific enzyme, no activity with 2-hydroxy-2-(trifluoromethyl)-pentanamide, 3,3,3-trifluoro-2-hydroxy-2-phenyl-propionamide, 3,3,3-trichloro-2-hydroxy-2-methylpropionamide, and 3,3,3-trifluoro-2-methoxy-2-methylpropionamide, overview
-
-
?
additional information
?
-
-
FAAH is a key regulator in the development of ethanol dependence
-
-
?
additional information
?
-
hardly hydrolyzes 2-arachidonoylglycerol
-
-
?
additional information
?
-
hardly hydrolyzes 2-arachidonoylglycerol
-
-
?
additional information
?
-
-
hardly hydrolyzes 2-arachidonoylglycerol
-
-
?
additional information
?
-
the enzyme NitN has an active site and a fold characteristic of the nitrilase superfamily, but shows only amidase activity, no nitrilase activity
-
-
?
additional information
?
-
the enzyme NitN has an active site and a fold characteristic of the nitrilase superfamily, but shows only amidase activity, no nitrilase activity
-
-
?
additional information
?
-
the PamH enzyme exhibits amidase activity, aryl acylamidase activity (EC 3.5.1.13), and acyl transferase activity. It shows excellent activity toward the majority of the aromatic and aliphatic amides, such as acetamide, propionamide, phenylacetamide, and benzamide. The aromatic amides, with substitutions of one or two carbons in the ring by a nitrogen, have a negative influence on amidase activity, leading to low specific activity values for pyrazinamide and nicotinamide. No activity is detectable on long-chain aliphatic amide hexanoamides. Amino acid amides are also hydrolyzed by the enzyme. The enzyme possesses urease activity, but N-methyl substituted is not hydrolyzed by the enzyme. The amidase shows low activity on asparagines (9%), L-glutamine (17%), and D-glutamine (13%) corresponding to benzamide (100%). The anilide substrate range of the enzyme is very narrow and cannot hydrolyze butachlor, acetochlor, 4-nitroacetanilide, p-chloroacetanilide, or other structurally analogous compounds
-
-
?
additional information
?
-
-
the enzyme catalyses the hydrolysis of small aliphatic amides
-
-
?
additional information
?
-
-
the enzyme catalyses the hydrolysis of small aliphatic amides
-
-
?
additional information
?
-
-
formation of acetohydroxamic acid using acetamide and hydroxylamine as substrates
-
-
?
additional information
?
-
-
formation of acetohydroxamic acid using acetamide and hydroxylamine as substrates
-
-
?
additional information
?
-
-
stereoselective enzyme
-
-
?
additional information
?
-
-
the enzyme also shows acyl transfer activity, ATA, forming nicotinyl hydroxamic acid and ammonia from nicotinamide and hydroxylamine, kinetics and substrate specificity, detailed overview. The acyl transfer activity of the amidase from Pseudomonas putida BR-1 rapidly catalyzes the biotransformation of short chain amides, i.e. acetamide and propionamide. Unsaturated amides, i.e. acrylamide and methacrylamide act as good substrates while amides having bulky side chain, i.e. L-tryptophanamide and DL-phenylglycinamide are poor substrates
-
-
?
additional information
?
-
-
stereoselective enzyme
-
-
?
additional information
?
-
-
the enzyme also shows acyl transfer activity, ATA, forming nicotinyl hydroxamic acid and ammonia from nicotinamide and hydroxylamine, kinetics and substrate specificity, detailed overview. The acyl transfer activity of the amidase from Pseudomonas putida BR-1 rapidly catalyzes the biotransformation of short chain amides, i.e. acetamide and propionamide. Unsaturated amides, i.e. acrylamide and methacrylamide act as good substrates while amides having bulky side chain, i.e. L-tryptophanamide and DL-phenylglycinamide are poor substrates
-
-
?
additional information
?
-
-
the enzyme is enantioselective, the enzyme also shows acyl transferase and hydrolase activities, no activity with N-methylurea, fumaramide, 4-aminobenzosulfonamide, N-phenylurea, acetanilide, benzylcarbamate, and o-tolylamide, broad substrate spectrum, including aliphatic, aromatic and amino acid amides, the presence of a double bond or a methyl group near the carboxamide group of aliphatic and amino acid amides enhances the enzymatic activity, among aromatic amides with substitutions at the 2-, 3-, or 4-position, the 4-substituted amides are the preferred substrates, detailed overview
-
-
?
additional information
?
-
no activity with: urea, benzamide, pyrazinamide, nicotinamide, cinnamamide, salicylamide
-
-
?
additional information
?
-
no activity with: urea, benzamide, pyrazinamide, nicotinamide, cinnamamide, salicylamide
-
-
?
additional information
?
-
-
no activity with: urea, benzamide, pyrazinamide, nicotinamide, cinnamamide, salicylamide
-
-
?
additional information
?
-
hardly hydrolyzes 2-arachidonoylglycerol
-
-
?
additional information
?
-
hardly hydrolyzes 2-arachidonoylglycerol
-
-
?
additional information
?
-
the enzyme is absolutely enantioselective, biocatalytic hydrolysis of cyanohydrins of amidase with nitrile hydratase, overview
-
-
?
additional information
?
-
-
the enzyme is absolutely enantioselective, biocatalytic hydrolysis of cyanohydrins of amidase with nitrile hydratase, overview
-
-
?
additional information
?
-
enantioselectivity toward (R)-4-chloro-3-hydroxybutyramide: e.e value 52% (conversion yield 57%)
-
-
?
additional information
?
-
-
enantioselectivity toward (R)-4-chloro-3-hydroxybutyramide: e.e value 52% (conversion yield 57%)
-
-
?
additional information
?
-
the enzyme is absolutely enantioselective, biocatalytic hydrolysis of cyanohydrins of amidase with nitrile hydratase, overview
-
-
?
additional information
?
-
enantioselectivity toward (R)-4-chloro-3-hydroxybutyramide: e.e value 52% (conversion yield 57%)
-
-
?
additional information
?
-
-
no activity with nicotinamide or benzamide
-
-
?
additional information
?
-
the Ser-cis Ser-Lys catalytic triad is located in the large domain. But the substrate-binding pocket is relatively narrow, due to the presence of the helix alpha13 in the small domain. The hydrophobic residues from the small domain are involved in recognizing the substrate. The small domain likely participates in substrate recognition and is related to the difference of substrate specificities among the AS family amidases
-
-
?
additional information
?
-
-
no activity with nicotinamide or benzamide
-
-
?
additional information
?
-
-
the amidase shows high enantioselectivity for (S)-arylpropionic amides, it is active on nitriles, molecular modelling, overview
-
-
?
additional information
?
-
the enzyme transfers the acyl group also to hydroxylamine and hydrazine
-
-
?
additional information
?
-
-
the enzyme transfers the acyl group also to hydroxylamine and hydrazine
-
-
?
additional information
?
-
the enzyme transfers the acyl group also to hydroxylamine and hydrazine
-
-
?
additional information
?
-
-
involved in the hydrolysis of the cell wall
-
-
?
additional information
?
-
substrate specificity, overview. The recombinant enzyme displays an unusually wide substrate spectrum. It is moderately active on short-chain aliphatic amides and weakly active hydrolyzing aromatic and heterocyclic amides. Recombinant His6-tagged enzyme Azl13 also catalyzes acyl transfer to hydroxylamine from acetamide or the herbicide propanil. The enzyme also shows aryl acylamide hydrolase activity, EC 3.5.1.13, and hydroxylamine acyl transferase activity, EC 2.3.1.56. No activity with L-glutamine and L-asparagine
-
-
?
additional information
?
-
-
other fatty acid ethanolamides may act as substrate
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(+/-)-(5Z,8Z,11Z,14Z)-N-((2,2-dimethyl-1,3-dioxolan-4-yl)methyl)icosa-5,8,11,14-tetraenamide
-
-
(+/-)-2,2-dimethyl-1,3-dioxolan-4-ylmethyl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate
-
-
(+/-)-oxiran-2-ylmethyl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate
-
-
(+/-)-oxiran-2-ylmethyl (9Z)-hexadec-9-enoate
-
-
(+/-)-oxiran-2-ylmethyl (9Z)-octadec-9-enoate
-
-
(+/-)-oxiran-2-ylmethyl (9Z,12Z)-octadeca-9,12-dienoate
-
-
(+/-)-oxiran-2-ylmethyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
-
-
(+/-)-oxiran-2-ylmethyl 1,1'-biphenyl-2-carboxylate
-
-
(+/-)-oxiran-2-ylmethyl 1,1'-biphenyl-3-carboxylate
-
-
(+/-)-oxiran-2-ylmethyl 1,1'-biphenyl-4-carboxylate
-
-
(+/-)-oxiran-2-ylmethyl benzoate
-
-
(+/-)-tetrahydro-2H-pyran-2-ylmethyl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate
-
-
(+/-)-tetrahydro-2H-pyran-2-ylmethyl (9Z)-hexadec-9-enoate
-
-
(+/-)-tetrahydro-2H-pyran-2-ylmethyl (9Z)-octadec-9-enoate
-
-
(+/-)-tetrahydro-2H-pyran-2-ylmethyl (9Z,12Z)-octadeca-9,12-dienoate
-
-
(+/-)-tetrahydro-2H-pyran-2-ylmethyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
-
-
(+/-)-tetrahydro-2H-pyran-2-ylmethyl 1,1'-biphenyl-2-carboxylate
-
-
(+/-)-tetrahydro-2H-pyran-2-ylmethyl 1,1'-biphenyl-3-carboxylate
-
-
(+/-)-tetrahydro-2H-pyran-2-ylmethyl 1,1'-biphenyl-4-carboxylate
-
-
(+/-)-tetrahydro-2H-pyran-2-ylmethyl benzoate
-
-
(2R,3R)-allo-2-methyl-4-oxo-3-oxetanylcarbamic acid tert-butyl ester
(2R,3S)-2-methyl-4-oxo-3-oxetanylcarbamic acid benzyl ester
(2R,3S)-2-methyl-4-oxo-3-oxetanylcarbamic acid tert-butyl ester
(2S,3R)-2-methyl-4-oxo-3-oxetanylcarbamic acid 5-phenylpentyl ester
(2S,3R)-2-methyl-4-oxo-3-oxetanylcarbamic acid benzyl ester
(2S,3R)-2-methyl-4-oxo-3-oxetanylcarbamic acid tert-butyl ester
(2S,3S)-allo-2-methyl-4-oxo-3-oxetanylcarbamic acid tert-butyl ester
(5Z,8Z,11Z,14Z)-eicosantetraenoic acid 3-thienyl methyl ester
(R)-(2-oxo-3-oxetanyl)carbamic acid tert-butyl ester
(R)-1-methyl-3-(2-oxo-3-oxetanyl)urea
(R)-2-oxo-3-oxetanylcarbamic acid benzyl ester
(R,S)-2-oxocyclobutylcarbamic acid benzyl ester
(S)-(2-oxo-3-oxetanyl)carbamic acid tert-butyl ester
(S)-1-methyl-3-(2-oxo-3-oxetanyl)urea
(S)-2-oxo-3-oxetanylcarbamic acid benzyl ester
1,10-phenanthroline
20-30% inhibition at 1 mM
1,3-benzodioxol-5-ylmethyl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate
-
-
1-(1,3-oxazol-2-yl)-3-(4-phenoxyphenyl)propan-1-one
-
-
1-(1,3-oxazol-2-yl)-3-[4-(phenoxymethyl)phenyl]propan-1-one
-
-
1-(1,3-oxazol-2-yl)-4-piperidin-4-ylbutan-1-one
-
-
1-(1,3-oxazol-2-yl)-4-[1-(3-phenylpropanoyl)piperidin-4-yl]butan-1-one
-
-
1-(1,3-oxazol-2-yl)-4-[1-(phenylacetyl)piperidin-4-yl]butan-1-one
-
-
1-(1,3-oxazol-2-yl)-4-[1-(phenylsulfonyl)piperidin-4-yl]butan-1-one
-
-
1-(1,3-oxazol-2-yl)-4-[1-[(2-phenylethyl)sulfonyl]piperidin-4-yl]butan-1-one
-
-
1-(1,3-oxazol-2-yl)-7-phenylheptan-1-one
-
-
1-(5-iodo-1,3-oxazol-2-yl)-3-(4-phenoxyphenyl)propan-1-one
-
-
1-(5-iodo-1,3-oxazol-2-yl)-3-[4-(phenoxymethyl)phenyl]propan-1-one
-
-
1-(5-iodo-1,3-oxazol-2-yl)-7-phenylheptan-1-one
-
-
1-(5-pyridin-2-yl-1,3-oxazol-2-yl)-7-(2-thienyl)heptan-1-one
-
-
1-(5-pyridin-2-yl-1,3-oxazol-2-yl)-7-(3-thienyl)heptan-1-one
-
-
1-(5-pyridin-2-yl-1,3-oxazol-2-yl)-7-[2-(trifluoromethyl)phenyl]hept-6-yn-1-one
-
-
1-(5-pyridin-2-yl-1,3-oxazol-2-yl)-7-[2-(trifluoromethyl)phenyl]heptan-1-one
-
-
1-(5-pyridin-2-yl-1,3-oxazol-2-yl)-7-[3-(trifluoromethyl)phenyl]hept-6-yn-1-one
-
-
1-(5-pyridin-2-yl-1,3-oxazol-2-yl)-7-[3-(trifluoromethyl)phenyl]heptan-1-one
-
-
1-(5-pyridin-2-yl-1,3-oxazol-2-yl)-7-[4-(trifluoromethyl)phenyl]hept-6-yn-1-one
-
-
1-(5-pyridin-2-yl-1,3-oxazol-2-yl)-7-[4-(trifluoromethyl)phenyl]heptan-1-one
-
-
1-([4'-[3-(1,3-oxazol-2-yl)propyl]biphenyl-4-yl]methyl)piperidine
-
-
1-arachidin
-
10% inhibition at 0.1 mM
1-myristin
-
IC50: 0.018, complete inhibition is possible
1-nor-arachidonoyl-3-(2'3-dihydroxypropyl) urea
-
i.e. O-1502, complete inhibition at 0.1 mM
1-palmitin
-
IC50: 0.0080, complete inhibition is possible
1-[6-(2-methyl-4,5-diphenyl-1H-imidazol-1-yl)hexyl]-3-phenylurea
-
-
11-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)undecan-1-one
-
-
2,3-dihydroxypropyl (11Z)-icos-11-enoate
-
i.e. O-4066, IC50: 0.010, complete inhibition is possible
2,3-dihydroxypropyl (11Z,14Z)-icosa-11,14-dienoate
-
i.e. O-3907, IC50: 0.0057, complete inhibition is possible
2,3-dihydroxypropyl (4Z,7Z,10Z,13Z)-17-ethylcycloheptadeca-4,7,10,13-tetraene-1-carboxylate
-
i.e. O-1428, 28% inhibition at 0.1 mM
2,3-dihydroxypropyl (5Z)-icos-5-enoate
-
i.e. 3908, IC50: 0.011, 84% inhibition is possible
2,3-dihydroxypropyl (5Z,8Z,11Z)-2-ethylcycloheptadeca-5,8,11-triene-1-carboxylate
-
i.e. O-3973, IC50: 0.0024, 95% inhibition is possible
2,3-dihydroxypropyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
-
i.e. O-3832, IC50: 0.0076, complete inhibition is possible
2,3-dihydroxypropyl (6Z,9Z,12Z,15Z)-cyclohenicosa-6,9,12,15-tetraene-1-carboxylate
-
i.e. O-4081, IC50: 0.0051, 90% inhibition is possible
2,3-dihydroxypropyl (7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoate
-
i.e. O-3872, IC50: 0.014, complete inhibition is possible
2,3-dihydroxypropyl (8Z,11Z,14Z)-icosa-8,11,14-trienoate
-
i.e. 3846, IC50: 0.023, complete inhibition is possible
2,6-difluorophenyl [6-[4,5-bis(4-fluorophenyl)-2-methyl-1H-imidazol-1-yl]hexyl]carbamate
-
-
2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazole-5-carbonitrile
-
-
2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazole-5-carboxamide
-
-
2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazole-5-carboxylic acid
-
-
2-(3-biphenyl-4-ylpropanoyl)-N,N-dimethyl-1,3-oxazole-5-carboxamide
-
-
2-(4-phenylbutoxy)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)ethanone
-
-
2-(5,5-dimethyl-1,3-dioxan-2-yl)ethyl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate
-
-
2-(7-phenylheptanoyl)-1,3-oxazole-5-carbonitrile
-
-
2-(7-phenylheptanoyl)-1,3-oxazole-5-carboxamide
-
-
2-(7-phenylheptanoyl)-1,3-oxazole-5-carboxylic acid
-
-
2-(hexadecyloxy)ethanamine
-
70% inhibition at 0.1 mM
2-aminoethyl decanoate
-
11% inhibition at 0.1 mM
2-aminoethyl dodecanoate
-
26% inhibition at 0.1 mM
2-aminoethyl hexadecanoate
-
50% inhibition at 0.1 mM
2-aminoethyl tetradecanoate
-
54% inhibition at 0.1 mM
2-arachidonoylglycerol
-
37% inhibition at 0.1 mM
2-chloro-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)ethanone
-
-
2-dodecyloxy-1-ethylamine
-
49% inhibition at 0.1 mM
2-fluorophenyl [1-ethyl-6-(2-methyl-4,5-diphenyl-1H-imidazol-1-yl)hexyl]carbamate
-
-
2-fluorophenyl [1-methyl-6-(2-methyl-4,5-diphenyl-1H-imidazol-1-yl)hexyl]carbamate
-
-
2-fluorophenyl [6-(2-methyl-4,5-diphenyl-1H-imidazol-1-yl)-1-(1-methylethyl)hexyl]carbamate
-
-
2-fluorophenyl [6-(2-methyl-4,5-diphenyl-1H-imidazol-1-yl)-1-phenylhexyl]carbamate
-
-
2-fluorophenyl [6-(2-methyl-4,5-diphenyl-1H-imidazol-1-yl)hexyl]carbamate
2-fluorophenyl [6-[4,5-bis(4-fluorophenyl)-2-methyl-1H-imidazol-1-yl]hexyl]carbamate
-
-
2-hydroxy-7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
2-tetradecyloxy-1-ethylamine
-
71% inhibition at 0.1 mM
2-[(4-phenylbutyl)sulfinyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)ethanone
-
-
2-[(4-phenylbutyl)sulfonyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)ethanone
-
-
2-[(4-phenylbutyl)thio]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)ethanone
-
-
2-[3-(4-phenoxyphenyl)propanoyl]-1,3-oxazole-5-carbonitrile
2-[3-(4-phenoxyphenyl)propanoyl]-1,3-oxazole-5-carboxamide
-
-
2-[3-(4-phenoxyphenyl)propanoyl]-1,3-oxazole-5-carboxylic acid
-
-
2-[3-(benzyloxy)phenoxy]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)ethanone
-
-
2-[3-[4-(phenoxymethyl)phenyl]propanoyl]-1,3-oxazole-5-carbonitrile
2-[3-[4-(phenoxymethyl)phenyl]propanoyl]-1,3-oxazole-5-carboxamide
-
-
2-[3-[4-(phenoxymethyl)phenyl]propanoyl]-1,3-oxazole-5-carboxylic acid
-
-
2-[4-(benzyloxy)phenoxy]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)ethanone
-
-
2-[methyl(4-phenylbutyl)amino]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)ethanol
-
-
3'-(aminocarbonyl)biphenyl-3-yl cyclohexylcarbamate
-
3'-carbamoyl-biphenyl-3-yl-cyclohexylcarbamate
3'-carbamoylbiphenyl-3-yl undec-10-yn-1-ylcarbamate
-
3'-{[(E)-(cyclohexylimino)(hydroxy)methyl]oxy}biphenyl-3-carboximidic acid
-
the inhibitor markedly increases the preference for ethanol. The inhibitor specifically acts through FAAH
3-(2-naphthyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
3-(3-phenylpropoxy)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
3-(4-anilinophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
3-(4-benzylphenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
3-(4-phenoxyphenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
3-(4-phenoxyphenyl)-1-[5-(trifluoromethyl)-1,3-oxazol-2-yl]propan-1-one
3-(4-phenylbutyl)oxetan-2-one
3-aminopropyl decanoate
-
45% inhibition at 0.1 mM
3-aminopropyl dodecanoate
-
37% inhibition at 0.1 mM
3-aminopropyl hexadecanoate
-
52% inhibition at 0.1 mM
3-aminopropyl tetradecanoate
-
54% inhibition at 0.1 mM
3-biphenyl-4-yl-1-(1,3-oxazol-2-yl)propan-1-one
-
-
3-biphenyl-4-yl-1-(5-iodo-1,3-oxazol-2-yl)propan-1-one
-
-
3-biphenyl-4-yl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
3-biphenyl-4-yl-1-(5-pyridin-3-yl-1,3-oxazol-2-yl)propan-1-one
-
-
3-biphenyl-4-yl-1-(5-pyridin-4-yl-1,3-oxazol-2-yl)propan-1-one
-
-
3-biphenyl-4-yl-1-[5-(methylthio)-1,3-oxazol-2-yl]propan-1-one
-
-
3-biphenyl-4-yl-1-[5-(trifluoroacetyl)-1,3-oxazol-2-yl]propan-1-one
-
-
3-biphenyl-4-yl-1-[5-(trifluoromethyl)-1,3-oxazol-2-yl]propan-1-one
-
-
3-biphenyl-4-yl-1-[5-[6-(1H-tetrazol-1-yl)pyridin-2-yl]-1,3-oxazol-2-yl]propan-1-one
-
-
3-dodecyloxy-1-propanamine
-
27% inhibition at 0.1 mM
3-hexadecyloxy-1-propanamine
-
16% inhibition at 0.1 mM
3-hydroxy-7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
3-tetradecyloxy-1-propanamine
-
29% inhibition at 0.1 mM
3-[3-(benzyloxy)phenyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
3-[4-(benzyloxy)cyclohexa-1,5-dien-1-yl]-1-[1,3]oxazolo[4,5-b]pyridin-2-ylpropan-1-one
-
-
3-[4-(benzyloxy)phenyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
3-[4-(phenoxymethyl)phenyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
3-[4-(phenoxymethyl)phenyl]-1-[5-(trifluoromethyl)-1,3-oxazol-2-yl]propan-1-one
3-[4-(phenoxymethyl)phenyl]-1-[5-[6-(1H-tetrazol-5-yl)pyridin-2-yl]-1,3-oxazol-2-yl]propan-1-one
-
-
3-[4-(phenylthio)phenyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
3-[4-[hydroxy(phenyl)methyl]cyclohexa-1,5-dien-1-yl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
3-[4-[hydroxy(phenyl)methyl]phenyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
3-[methyl(3-phenylpropyl)amino]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
4-(1-benzoylpiperidin-4-yl)-1-(1,3-oxazol-2-yl)butan-1-one
-
-
4-(1-benzylpiperidin-4-yl)-1-(1,3-oxazol-2-yl)butan-1-one
-
-
4-(2-phenylethoxy)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)butan-1-one
-
-
4-(benzyloxy)phenyl butylcarbamate
-
4-chloromercuribenzoic acid
-
as -SH-blocking reagent, substrate 4-nitroacetanilide, incubation 10 min, 10 micromol 4-chloromercuribenzoic acid, residual activity 4.8%, activity restored by addition of 1 mM cysteine, 1 h incubation 67% restored
4-chloromercurybenzoate
-
4-hydroxy-7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
4-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)butan-1-one
-
-
4-[1-(2-bromobenzyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
-
-
4-[1-(2-chlorobenzyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
-
-
4-[1-(2-methoxybenzyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
-
-
4-[1-(2-methylbenzyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
-
-
4-[1-(3,3-dimethylbutanoyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
-
-
4-[1-(3-bromobenzyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
-
-
4-[1-(3-chlorobenzyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
-
-
4-[1-(3-cyclohexylpropanoyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
-
-
4-[1-(3-methoxybenzyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
-
-
4-[1-(3-methylbenzyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
-
-
4-[1-(4-bromobenzyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
-
-
4-[1-(4-chlorobenzyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
-
-
4-[1-(4-methoxybenzyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
-
-
4-[1-(4-methylbenzyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
-
-
4-[1-(benzylsulfonyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
-
-
4-[1-(cyclohexylacetyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
-
-
4-[1-(cyclohexylcarbonyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
-
-
4-[1-(cyclopropylcarbonyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
-
-
4-[1-(isopropylsulfonyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
-
-
4-[1-[3-(1-methylethoxy)benzyl]piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
-
-
4-[1-[3-(1-methylethyl)benzyl]piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
-
-
4-[1-[4-(1-methylethoxy)benzyl]piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
-
-
4-[1-[4-(1-methylethyl)benzyl]piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
-
-
4-[2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazol-5-yl]pyridine-2-carboxylic acid
-
-
4-[methyl(2-phenylethyl)amino]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)butan-1-one
-
-
5-(benzyloxy)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)pentan-1-one
-
-
5-(benzylsulfinyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)pentan-1-one
-
-
5-(benzylthio)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)pentan-1-one
5-hydroxy-7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
5-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)pentan-1-one
-
-
5-[2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazol-5-yl]pyridine-2-carboxylic acid
-
-
5-[benzyl(methyl)amino]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)pentan-1-one
6-(2-[3-[4'-(morpholin-4-ylmethyl)biphenyl-4-yl]propyl]-1,3-oxazol-5-yl)pyridine-2-carboxylic acid
-
-
6-(2-[3-[4'-(piperidin-1-ylmethyl)biphenyl-4-yl]propyl]-1,3-oxazol-5-yl)pyridine-2-carboxylic acid
-
-
6-(2-[3-[4'-(pyrrolidin-1-ylmethyl)biphenyl-4-yl]propyl]-1,3-oxazol-5-yl)pyridine-2-carboxylic acid
-
-
6-(2-[3-[4'-(thiomorpholin-4-ylmethyl)biphenyl-4-yl]propyl]-1,3-oxazol-5-yl)pyridine-2-carboxylic acid
-
-
6-(2-[3-[4-(phenoxymethyl)phenyl]propanoyl]-1,3-oxazol-5-yl)pyridine-2-carbonitrile
-
-
6-(2-[3-[4-(phenoxymethyl)phenyl]propanoyl]-1,3-oxazol-5-yl)pyridine-2-carboxylic acid
-
-
6-(2-[3-[4-(phenoxymethyl)phenyl]propanoyl]-1,3-oxazol-5-yl)pyridine-3-carboxylic acid
-
-
6-(2-[3-[4-(piperidin-4-yloxy)phenyl]propyl]-1,3-oxazol-5-yl)pyridine-2-carboxylic acid
-
-
6-(benzyloxy)-N-[(3S)-2-oxooxetan-3-yl]naphthalene-2-carboxamide
6-(phenylsulfinyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hexan-1-one
-
-
6-(phenylsulfonyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hexan-1-one
-
-
6-(phenylthio)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hexan-1-one
-
-
6-hydroxy-7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
6-methoxy-N-[(3S)-2-oxooxetan-3-yl]naphthalene-2-carboxamide
6-oxo-N-phenyl-6-(5-pyridin-2-yl-1,3-oxazol-2-yl)hexanamide
-
-
6-phenoxy-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hexan-1-one
-
-
6-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hexan-1-one
-
-
6-[2-(3-biphenyl-4-yl-1-hydroxypropyl)-1,3-oxazol-5-yl]nicotinic acid
-
-
6-[2-(3-biphenyl-4-yl-1-hydroxypropyl)-1,3-oxazol-5-yl]pyridine-2-carboxamide
-
-
6-[2-(3-biphenyl-4-yl-1-hydroxypropyl)-1,3-oxazol-5-yl]pyridine-2-carboxylic acid
-
-
6-[2-(3-biphenyl-4-yl-1-hydroxypropyl)-1,3-oxazol-5-yl]pyridine-3-carboxamide
-
-
6-[2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazol-5-yl]nicotinamide
-
-
6-[2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazol-5-yl]nicotinic acid
-
-
6-[2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazol-5-yl]pyridine-2-carbonitrile
-
-
6-[2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazol-5-yl]pyridine-2-carboxamide
-
-
6-[2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazol-5-yl]pyridine-2-carboxylic acid
-
-
6-[2-(3-biphenyl-4-ylpropyl)-1,3-oxazol-5-yl]nicotinamide
-
-
6-[2-(3-biphenyl-4-ylpropyl)-1,3-oxazol-5-yl]nicotinic acid
-
-
6-[2-(3-biphenyl-4-ylpropyl)-1,3-oxazol-5-yl]pyridine-2-carboxamide
-
-
6-[2-(3-biphenyl-4-ylpropyl)-1,3-oxazol-5-yl]pyridine-2-carboxylic acid
-
-
6-[2-(3-[4'-[(4-aminopiperazin-1-yl)methyl]biphenyl-4-yl]propyl)-1,3-oxazol-5-yl]pyridine-2-carboxylic acid
-
-
6-[2-(7-phenylheptanoyl)-1,3-oxazol-5-yl]nicotinic acid
-
-
6-[2-(7-phenylheptanoyl)-1,3-oxazol-5-yl]pyridine-2-carbonitrile
-
-
6-[2-(7-phenylheptanoyl)-1,3-oxazol-5-yl]pyridine-2-carboxylic acid
-
-
6-[2-[3-(4-phenoxyphenyl)propanoyl]-1,3-oxazol-5-yl]nicotinic acid
-
-
6-[2-[3-(4-phenoxyphenyl)propanoyl]-1,3-oxazol-5-yl]pyridine-2-carboxylic acid
-
-
6-[2-[3-(4-[[1-(tert-butoxycarbonyl)piperidin-4-yl]oxy]phenyl)propyl]-1,3-oxazol-5-yl]pyridine-2-carboxylic acid
-
-
6-[methyl(phenyl)amino]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hexan-1-one
-
-
7-(2,3-dichlorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one
-
-
7-(2,3-dichlorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
7-(2-chlorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one
-
-
7-(2-chlorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
7-(2-fluorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one
-
-
7-(2-fluorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
7-(2-methoxyphenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
7-(2-methylphenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
7-(2-nitrophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one
-
-
7-(3-aminophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
7-(3-chlorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one
-
-
7-(3-chlorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
7-(3-fluorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one
-
-
7-(3-fluorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
7-(3-methoxyphenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
7-(3-methylphenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
7-(3-nitrophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one
-
-
7-(4-aminophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
7-(4-chlorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one
-
-
7-(4-chlorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
7-(4-fluorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one
-
-
7-(4-fluorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
7-(4-methoxyphenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
7-(4-methylphenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
7-(4-nitrophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one
-
-
7-(4-nitrophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
7-hydroxy-7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
7-naphthalen-1-yl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
7-naphthalen-2-yl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one
-
-
7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
7-phenyl-1-[5-(trifluoromethyl)-1,3-oxazol-2-yl]heptan-1-one
-
-
7-phenyl-1-[5-[6-(1H-tetrazol-5-yl)pyridin-2-yl]-1,3-oxazol-2-yl]heptan-1-one
-
-
7-pyridin-2-yl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one
-
-
7-pyridin-2-yl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
7-pyridin-3-yl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one
-
-
7-pyridin-3-yl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
7-pyridin-4-yl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one
-
-
7-[2-(methylsulfanyl)phenyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
7-[3-(methylsulfanyl)phenyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
7-[3-(tert-butylamino)phenyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
7-[4-(methylsulfanyl)phenyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
7-[4-(tert-butylamino)phenyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
8-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)octan-1-one
-
-
9-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)nonan-1-one
-
-
acetanilide
-
substrate 4-nitroacetanilide, Ki: 14 micromol, competitive inhibition
acetonitrile
-
5% v/v, 93% inhibition; 93% decreased activity at 5% (v/v)
acetonnitrile
-
Ki: 120 mM
Acrylamide
-
substrate inhibition
acrylonitrile
-
Ki: 34 mM
alpha-methyl-1-arachidonoylglycerol
-
IC50: 0.033 mM, complete inhibition at 0.1 mM
ammonia
-
non-competitive product inhibitor at pH 9.0
arachidonic acid
-
IC50: 0.058 mM, complete inhibition at 0.1 mM
arachidonoyl glycine
-
IC50: 0.0049 mM, complete inhibition at 0.1 mM
arachidonoyl serinol
-
IC50: 0.078 mM, complete inhibition at 0.1 mM
arachidonoyl serotonin
-
more potent inhibitor at pH 8.4 than at pH 5.3
benzyl 4-[4-(1,3-oxazol-2-yl)-4-oxobutyl]piperidine-1-carboxylate
-
-
CaCl2
-
relative activity 91.7%, incubated for 10 min
Chloroacetone
-
pH 8.66, 25°C, irreversible strong inhibition at concentrations of 0.1 mM and above, acetamide protects enzyme from inhibition and slowly recovers activity of inactivated enzyme
Cyanate
-
Ki of strain AI3 is 1.1 mM, Ki of strain AIU1N is 1.8 mM and Ki of strain OUCH4 is 50 mM; reversible inhibition, pH 7.2 and 37°C
cyclobutylcarbamic acid benzyl ester
cyclopentyl(5-pyridin-2-yl-1,3-oxazol-2-yl)methanone
-
-
cyclopropyl(5-pyridin-2-yl-1,3-oxazol-2-yl)methanone
-
-
Diethyl-4-nitrophenyl phosphate
-
-
diisopropylphosphorofluoridate
-
-
Dimethyl sulfide
-
5% v/v, complete inhibition; complete inhibition at 5% (v/v)
dimethyl sulfoxide
-
5% v/v, complete inhibition; complete inhibition at 5% (v/v)
DNA containing thymine glycol
-
dodecyl 2-aminoacetate
-
66% inhibition at 0.1 mM
dodecyl 3-aminopropanoate
-
27% inhibition at 0.1 mM
DTT
-
21% inhibition at 1 mM
ethyl 4-[3-(4,5-diphenyl-1H-imidazol-1-yl)phenoxy]butanoate
-
-
ethyl 4-[4-(4,5-diphenyl-1H-imidazol-1-yl)phenoxy]butanoate
-
-
ethyl 6-(2-ethyl-4,5-diphenyl-1H-imidazol-1-yl)hexanoate
-
-
ethyl 6-[2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazol-5-yl]pyridine-2-carboxylate
-
-
ethyl 6-[[(3S)-2-oxooxetan-3-yl]carbamoyl]naphthalene-2-carboxylate
ethyl 7-(2-ethyl-4,5-diphenyl-1H-imidazol-1-yl)heptanoate
-
-
ethyl 7-[4,5-bis(4-fluorophenyl)-2-methyl-1H-imidazol-1-yl]heptanoate
-
-
ethyl 8-(2-ethyl-4,5-diphenyl-1H-imidazol-1-yl)octanoate
-
-
H2O2
-
5% v/v, complete inhibition; complete inhibition at 5% (v/v) H2O2
hexadecyl 2-aminoacetate
-
29% inhibition at 0.1 mM
hexadecyltrimethylammonium chloride
-
-
hydroxylamine
-
competitive inhibitor at pH 7.2
Hydroxyurea
-
Ki of strain AI3 is 1.4 mM, Ki of strain AIU1N is 10.8 mM and Ki of strain OUCH4 is 337 mM, regaines full activity within 24 h at 37°C in 0.05 M Tris buffer at pH 7.2; reversible inhibition, pH 7.2 and 37°C
Ibuprofen
-
both enantiomers, more potent inhibitors at pH 5.3 than at pH 8.4
isopropyl 4-[4-(1,3-oxazol-2-yl)-4-oxobutyl]piperidine-1-carboxylate
-
-
K+
-
1-linear competitive inhibition of the amidase activity
L-ascorbic acid
-
19% inhibition at 1 mM
mercaptoethanol
-
5% v/v, complete inhibition
Methacrylonitrile
-
Ki: 90 mM
methyl 2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazole-5-carboxylate
methyl 2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazole-5-sulfinate
-
-
methyl 2-(7-phenylheptanoyl)-1,3-oxazole-5-carboxylate
-
-
methyl 2-[3-(4-phenoxyphenyl)propanoyl]-1,3-oxazole-5-carboxylate
-
-
methyl 2-[3-[4-(phenoxymethyl)phenyl]propanoyl]-1,3-oxazole-5-carboxylate
-
-
methyl 2-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-1-yn-1-yl]benzoate
-
-
methyl 2-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptyl]benzenesulfinate
-
-
methyl 2-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptyl]benzoate
-
-
methyl 3-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-1-yn-1-yl]benzoate
-
-
methyl 3-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptyl]benzenesulfinate
-
-
methyl 3-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptyl]benzoate
-
-
methyl 4-[2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazol-5-yl]pyridine-2-carboxylate
-
-
methyl 4-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-1-yn-1-yl]benzoate
-
-
methyl 4-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptyl]benzenesulfinate
-
-
methyl 4-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptyl]benzoate
-
-
methyl 5-oxo-5-(5-pyridin-2-yl-1,3-oxazol-2-yl)pentanoate
-
-
methyl 5-[2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazol-5-yl]pyridine-2-carboxylate
-
-
methyl 6-(2-[3-[4'-(morpholin-4-ylmethyl)biphenyl-4-yl]propyl]-1,3-oxazol-5-yl)pyridine-2-carboxylate
-
-
methyl 6-(2-[3-[4'-(piperidin-1-ylmethyl)biphenyl-4-yl]propyl]-1,3-oxazol-5-yl)pyridine-2-carboxylate
-
-
methyl 6-(2-[3-[4'-(pyrrolidin-1-ylmethyl)biphenyl-4-yl]propyl]-1,3-oxazol-5-yl)pyridine-2-carboxylate
-
-
methyl 6-(2-[3-[4'-(thiomorpholin-4-ylmethyl)biphenyl-4-yl]propyl]-1,3-oxazol-5-yl)pyridine-2-carboxylate
-
-
methyl 6-(2-[3-[4-(phenoxymethyl)phenyl]propanoyl]-1,3-oxazol-5-yl)pyridine-2-carboxylate
-
-
methyl 6-(2-[3-[4-(phenoxymethyl)phenyl]propanoyl]-1,3-oxazol-5-yl)pyridine-3-carboxylate
-
-
methyl 6-(2-[3-[4-(piperidin-4-yloxy)phenyl]propyl]-1,3-oxazol-5-yl)pyridine-2-carboxylate
-
-
methyl 6-oxo-6-(5-pyridin-2-yl-1,3-oxazol-2-yl)hexanoate
-
-
methyl 6-[2-(3-biphenyl-4-yl-1-hydroxypropyl)-1,3-oxazol-5-yl]pyridine-2-carboxylate
-
-
methyl 6-[2-(3-biphenyl-4-yl-1-hydroxypropyl)-1,3-oxazol-5-yl]pyridine-3-carboxylate
-
-
methyl 6-[2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazol-5-yl]pyridine-2-carboxylate
methyl 6-[2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazol-5-yl]pyridine-3-carboxylate
-
-
methyl 6-[2-(3-biphenyl-4-ylpropyl)-1,3-oxazol-5-yl]pyridine-2-carboxylate
-
-
methyl 6-[2-(3-biphenyl-4-ylpropyl)-1,3-oxazol-5-yl]pyridine-3-carboxylate
-
-
methyl 6-[2-(3-[4'-[(dimethylamino)methyl]biphenyl-4-yl]propyl)-1,3-oxazol-5-yl]pyridine-2-carboxylate
-
-
methyl 6-[2-(7-phenylheptanoyl)-1,3-oxazol-5-yl]pyridine-2-carboxylate
-
-
methyl 6-[2-(7-phenylheptanoyl)-1,3-oxazol-5-yl]pyridine-3-carboxylate
-
-
methyl 6-[2-[3-(4-phenoxyphenyl)propanoyl]-1,3-oxazol-5-yl]pyridine-2-carboxylate
-
-
methyl 6-[2-[3-(4-phenoxyphenyl)propanoyl]-1,3-oxazol-5-yl]pyridine-3-carboxylate
-
-
methyl 6-[2-[3-(4-[[1-(tert-butoxycarbonyl)piperidin-4-yl]oxy]phenyl)propyl]-1,3-oxazol-5-yl]pyridine-2-carboxylate
-
-
methyl [3-(4,5-diphenyl-1H-imidazol-1-yl)phenoxy]acetate
-
-
methyl [4-(4,5-diphenyl-1H-imidazol-1-yl)phenoxy]acetate
-
-
MnCl2
-
relative activity 94.4%, incubated for 10 min
N,N-dimethyl-2-(7-phenylheptanoyl)-1,3-oxazole-5-carboxamide
-
-
N,N-dimethyl-2-[3-(4-phenoxyphenyl)propanoyl]-1,3-oxazole-5-carboxamide
-
-
N,N-dimethyl-2-[3-[4-(phenoxymethyl)phenyl]propanoyl]-1,3-oxazole-5-carboxamide
-
-
N,N-dimethyl-7-(2-methyl-4,5-diphenyl-1H-imidazol-1-yl)heptanamide
-
-
N-(4-hydroxy-2-methylphenyl)arachidonylamide
-
i.e. VDM11, an anandamide uptake inhibitor, IC50 is 0.0026 mM, inhibitory potency depends upon the concentration of bovine serum albumin
N-(4-hydroxyphenyl)arachidonylamide
-
i.e. AM404, an anandamide uptake inhibitor, IC50 is 0.0021 mM
N-(cyclohexylcarbonyl)pentadecylamine
N-benzyl-5-oxo-5-(5-pyridin-2-yl-1,3-oxazol-2-yl)pentanamide
-
-
n-butanol
-
48% decreased activity at 5% (v/v); 5% v/v, 48% inhibition
N-ethylmaleimide
-
inhibition at 10 mM, C-amidase
N-methyl-2-(7-phenylheptanoyl)-1,3-oxazole-5-carboxamide
-
-
N-methyl-2-[3-(4-phenoxyphenyl)propanoyl]-1,3-oxazole-5-carboxamide
-
-
N-methyl-2-[3-[4-(phenoxymethyl)phenyl]propanoyl]-1,3-oxazole-5-carboxamide
-
-
N-methyl-7-(2-methyl-4,5-diphenyl-1H-imidazol-1-yl)heptanamide
-
-
N-methylpropionamide
-
amide analogue, inhibits the biosynthesis of acetamidase, strain R312
N-[(3S)-2-oxooxetan-3-yl]biphenyl-4-carboxamide
N-[(3S)-2-oxooxetan-3-yl]naphthalene-2-carboxamide
N-[(benzyloxy)carbonyl]-D-serine
N-[(benzyloxy)carbonyl]-L-serine
NH3
-
selective product inhibition
noladin ether
-
IC50: 0.003 mM, complete inhibition at 0.1 mM
o-Nitrophenol
-
competitive inhibition
oleoyltrifluoromethylketone
-
more potent inhibitor at pH 5.3 than at pH 8.4
OMDM2
-
0.01 mM, 16% inhibition
p-chloromercuribenzoate
-
relative activity 36.1%, incubated for 10 min
PEG
-
8% inhibition at 1 mM
pentadecyl 2-aminoacetate
-
56% inhibition at 0.1 mM
pentadecyl 3-aminopropanoate
-
27% inhibition at 0.1 mM
Phenacetin
-
substrate 4-nitroacetanilide, Ki: 8.9 nM, competitive inhibition, induction of activity for 2-nitrophenylacetate and methylbutyrate
Phenetidine
-
uncompetitive inhibition
phenyl 6-[[(3S)-2-oxooxetan-3-yl]carbamoyl]naphthalene-2-carboxylate
phenyl hydrazine
-
complete inhibition at 1 mM
phenyl [6-(2-methyl-4,5-diphenyl-1H-imidazol-1-yl)hexyl]carbamate
-
-
phenylmethanesulfonyl fluoride
phenylmethyl sulfonyl fluoride
-
more potent inhibitor at pH 8.4 than at pH 5.3
phenylphosphorodiamidate
-
competitive inhibitor, the inhibitory effect is fully reversed by SSAM substrate benzamide, demonstrating the hydrophobicity of the active site
physostigmine sulfate
-
-
Propionitrile
-
Ki: 280 mM
specific iron chelator
-
-
-
suberoylanilide hydroxamic acid
strong inhibition
succinate
Blastobacter sp.
-
-
sulfhydyl reagents
Blastobacter sp.
-
-
-
tert-butyl 4-[4-(1,3-oxazol-2-yl)-4-oxobutyl]piperidine-1-carboxylate
-
-
tert-butyl [3-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-1-yn-1-yl]phenyl]carbamate
-
-
tert-butyl [4-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-1-yn-1-yl]phenyl]carbamate
-
-
tetradecyl 2-aminoacetate
-
84% inhibition at 0.1 mM
tetrahydro-2H-pyran-4-yl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate
-
-
Thioacetamide
-
amide analogues, inhibits the biosynthesis of acetamidase, strain R312
thiol blocking reagent
-
-
-
tricostatin A
strong inhibition
tridecyl 2-aminoacetate
-
89% inhibition at 0.1 mM
tridecyl 3-aminopropanoate
-
27% inhibition at 0.1 mM
(2R,3R)-allo-2-methyl-4-oxo-3-oxetanylcarbamic acid tert-butyl ester
-
-
(2R,3R)-allo-2-methyl-4-oxo-3-oxetanylcarbamic acid tert-butyl ester
-
-
(2R,3S)-2-methyl-4-oxo-3-oxetanylcarbamic acid benzyl ester
-
-
(2R,3S)-2-methyl-4-oxo-3-oxetanylcarbamic acid benzyl ester
-
-
(2R,3S)-2-methyl-4-oxo-3-oxetanylcarbamic acid tert-butyl ester
-
-
(2R,3S)-2-methyl-4-oxo-3-oxetanylcarbamic acid tert-butyl ester
-
-
(2S,3R)-2-methyl-4-oxo-3-oxetanylcarbamic acid 5-phenylpentyl ester
-
potent inhibitor, rapidly cleaved in plasma
(2S,3R)-2-methyl-4-oxo-3-oxetanylcarbamic acid 5-phenylpentyl ester
-
potent inhibitor, rapidly cleaved in plasma
(2S,3R)-2-methyl-4-oxo-3-oxetanylcarbamic acid benzyl ester
-
-
(2S,3R)-2-methyl-4-oxo-3-oxetanylcarbamic acid benzyl ester
-
-
(2S,3R)-2-methyl-4-oxo-3-oxetanylcarbamic acid tert-butyl ester
-
-
(2S,3R)-2-methyl-4-oxo-3-oxetanylcarbamic acid tert-butyl ester
-
-
(2S,3S)-allo-2-methyl-4-oxo-3-oxetanylcarbamic acid tert-butyl ester
-
-
(2S,3S)-allo-2-methyl-4-oxo-3-oxetanylcarbamic acid tert-butyl ester
-
-
(5Z,8Z,11Z,14Z)-eicosantetraenoic acid 3-thienyl methyl ester
-
i.e. CAY-10402, IC50: 0.010 mM, 37% inhibition at 0.1 mM
(5Z,8Z,11Z,14Z)-eicosantetraenoic acid 3-thienyl methyl ester
-
i.e. CAY-10402
(R)-(2-oxo-3-oxetanyl)carbamic acid tert-butyl ester
-
-
(R)-(2-oxo-3-oxetanyl)carbamic acid tert-butyl ester
-
-
(R)-1-methyl-3-(2-oxo-3-oxetanyl)urea
-
-
(R)-1-methyl-3-(2-oxo-3-oxetanyl)urea
-
-
(R)-2-oxo-3-oxetanylcarbamic acid benzyl ester
-
-
(R)-2-oxo-3-oxetanylcarbamic acid benzyl ester
-
-
(R,S)-2-oxocyclobutylcarbamic acid benzyl ester
-
weak inhibition
(R,S)-2-oxocyclobutylcarbamic acid benzyl ester
-
weak inhibition
(S)-(2-oxo-3-oxetanyl)carbamic acid tert-butyl ester
-
-
(S)-(2-oxo-3-oxetanyl)carbamic acid tert-butyl ester
-
-
(S)-1-methyl-3-(2-oxo-3-oxetanyl)urea
-
-
(S)-1-methyl-3-(2-oxo-3-oxetanyl)urea
-
-
(S)-2-oxo-3-oxetanylcarbamic acid benzyl ester
-
-
(S)-2-oxo-3-oxetanylcarbamic acid benzyl ester
-
-
1-arachidonoylglycerol
-
IC50: 0.0062 mM
1-arachidonoylglycerol
-
42% inhibition at 0.1 mM
2-fluorophenyl [6-(2-methyl-4,5-diphenyl-1H-imidazol-1-yl)hexyl]carbamate
-
-
2-fluorophenyl [6-(2-methyl-4,5-diphenyl-1H-imidazol-1-yl)hexyl]carbamate
-
potentiates the effects of exogenous anandamide (1 mg/kg, iv) in a rat thermal escape test (Hargreaves test), and shows robust antinociceptive activity in (1 mg/kg, iv) in a rat thermal escape test (Hargreaves test), and shows robust antinociceptive activity in animal models of persistent (formalin test) and neuropathic (Chung model) pain
2-mercaptoethanol
-
complete inhibition at 5% (v/v) 2-mercaptoethanol
2-mercaptoethanol
-
9% inhibition at 1 mM
2-mercaptoethanol
52% inhibition at 1 mM
2-[3-(4-phenoxyphenyl)propanoyl]-1,3-oxazole-5-carbonitrile
-
-
2-[3-(4-phenoxyphenyl)propanoyl]-1,3-oxazole-5-carbonitrile
-
-
2-[3-[4-(phenoxymethyl)phenyl]propanoyl]-1,3-oxazole-5-carbonitrile
-
-
2-[3-[4-(phenoxymethyl)phenyl]propanoyl]-1,3-oxazole-5-carbonitrile
-
-
3'-carbamoyl-biphenyl-3-yl-cyclohexylcarbamate
-
i.e. URB597, specific, complete inhibition at 0.001 mM
3'-carbamoyl-biphenyl-3-yl-cyclohexylcarbamate
-
i.e. URB597, specific
3-(4-phenoxyphenyl)-1-[5-(trifluoromethyl)-1,3-oxazol-2-yl]propan-1-one
-
-
3-(4-phenoxyphenyl)-1-[5-(trifluoromethyl)-1,3-oxazol-2-yl]propan-1-one
-
-
3-(4-phenylbutyl)oxetan-2-one
-
-
3-(4-phenylbutyl)oxetan-2-one
-
-
3-biphenyl-4-yl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
3-biphenyl-4-yl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
3-[4-(benzyloxy)phenyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
3-[4-(benzyloxy)phenyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
3-[4-(phenoxymethyl)phenyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
3-[4-(phenoxymethyl)phenyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
3-[4-(phenoxymethyl)phenyl]-1-[5-(trifluoromethyl)-1,3-oxazol-2-yl]propan-1-one
-
-
3-[4-(phenoxymethyl)phenyl]-1-[5-(trifluoromethyl)-1,3-oxazol-2-yl]propan-1-one
-
-
3-[4-[hydroxy(phenyl)methyl]cyclohexa-1,5-dien-1-yl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
3-[4-[hydroxy(phenyl)methyl]cyclohexa-1,5-dien-1-yl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
5-(benzylthio)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)pentan-1-one
-
-
5-(benzylthio)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)pentan-1-one
-
-
5-[benzyl(methyl)amino]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)pentan-1-one
-
-
5-[benzyl(methyl)amino]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)pentan-1-one
-
-
6-(benzyloxy)-N-[(3S)-2-oxooxetan-3-yl]naphthalene-2-carboxamide
-
-
6-(benzyloxy)-N-[(3S)-2-oxooxetan-3-yl]naphthalene-2-carboxamide
-
-
6-methoxy-N-[(3S)-2-oxooxetan-3-yl]naphthalene-2-carboxamide
-
-
6-methoxy-N-[(3S)-2-oxooxetan-3-yl]naphthalene-2-carboxamide
-
-
7-(2,3-dichlorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
7-(2,3-dichlorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
acetaldehyde
-
-
acetaldehyde
-
competitive inhibitor, not time dependent; competitve inhibitor, Ki: 7.0 micromol
acetamide
-
substrate inhibition
acetamide
-
no inhibition up to 1.0 M concentration in presence of 0.56 mg protein
acetamide
-
non-competitive inhibitor
acetic acid
-
Ki: 240 mM
acetic acid
-
competitive product inhibitor at pH 5.7
acetone
-
5% v/v, 86% inhibition; 86% decreased activity at 5% (v/v)
acetone
25% (v/v), 69% inhibition
Ag+
-
complete inhibition at 1 mM
Ag+
Blastobacter sp.
-
inactivates enzyme activity by 76%
Ag+
-
22% of origin activity
Ag+
-
complete inhibition at 1 mM
Ag+
-
preincubation for 30 min, remaining activity in presence of 1 mM DTT
Ag+
-
0% of origin activity
Ag+
complete inhibition at 1 mM
Al3+
-
-
Al3+
-
2-linear mixed-type inhibition of the amidase activity
Ba2+
-
11% inhibition at 1 mM
Ba2+
-
13% inhibition at 1 mM
Ca2+
-
10% inhibition at 1 mM
Ca2+
-
1-linear competitive inhibition of the amidase activity
Ca2+
-
15% inhibition at 1 mM
Ca2+
10 mM, 12% inhibition
Cd2+
-
98% inhibition at 1 mM
Cd2+
Blastobacter sp.
-
inactivates enzyme activity by 79%
Cd2+
-
preincubated for 30 min
Cd2+
complete inhibition at 1 mM
Co2+
-
89-48% residual activity at 1 mM
Co2+
-
52% inhibition at 1 mM
Co2+
-
9% inhibition at 1 mM
Co2+
-
complete inhibition at 1 mM
Co2+
10 mM, 41% inhibition
Cr2+
-
-
Cu2+
-
89-48% residual activity at 1 mM
Cu2+
-
complete inhibition at 1 mM
Cu2+
Blastobacter sp.
-
inactivates enzyme activity by 90%
Cu2+
-
relative activity 0%, incubated for 10 min
Cu2+
-
58% of origin activity
Cu2+
-
28.5% inhibition at 1 mM
Cu2+
-
preincubated for 30 min, remaining activity in presence of 1 mM DTT
Cu2+
-
74% inhibition at 1 mM
Cu2+
10 mM, 69% inhibition
Cu2+
-
0% of origin activity
Cu2+
complete inhibition at 1 mM
cyclobutylcarbamic acid benzyl ester
-
weak inhibition
cyclobutylcarbamic acid benzyl ester
-
weak inhibition
dithiothreitol
-
80% residual activity at 1 mM
dithiothreitol
-
97% of origin activity
DNA containing thymine glycol
-
-
DNA containing thymine glycol
-
-
DNA containing thymine glycol
-
-
DNA containing thymine glycol
-
-
DTNB
-
15-18% inhibition of wild-type, MM6 and MM8, 35% inhibition of the MM15 activity
DTNB
-
preincubated for 30 min, remaining activity in presence of 1 mM DTT
EDTA
-
21% inhibition at 1 mM
EDTA
-
10 mM, loss of amidase activity of less than 5%
EDTA
20-30% inhibition at 1 mM
ethanol
-
58% decreased activity at 5% (v/v); 5% v/v, 58% inhibition
ethanol
25% (v/v), 45% inhibition
ethyl 6-[[(3S)-2-oxooxetan-3-yl]carbamoyl]naphthalene-2-carboxylate
-
-
ethyl 6-[[(3S)-2-oxooxetan-3-yl]carbamoyl]naphthalene-2-carboxylate
-
-
Fe2+
-
-
Fe2+
-
58% of origin activity
Fe2+
-
preincubated for 30 min
Fe2+
-
20% inhibition at 1 mM
Fe3+
-
89-48% residual activity at 1 mM
Fe3+
-
87% inhibition at 1 mM
Fe3+
10 mM, 68% inhibition
Hg2+
-
complete inhibition at 1 mM
Hg2+
Blastobacter sp.
-
inactivates enzyme activity by 99%
Hg2+
-
relative activity 91.7%, incubated for 10 min
Hg2+
-
HgCl2 as -SH-blocking reagent, incubation 10 min, 10 micromol HgCl2, 81% of activity restored by addition of 1 mM cysteine
Hg2+
-
7% of the original activity
Hg2+
-
complete inhibition at 1 mM
Hg2+
-
complete inhibition at 1 mM
Hg2+
complete inhibition at 1 mM
iodoacetamide
-
concentration 0.2 M at pH 8.0
iodoacetamide
-
hydrolase activity kcat: 0.033 per min with 10 mM at pH 7.0 and 25°C, transferase activity 75%, remaining activity less than 2%
iodoacetamide
-
no effect of 2-chloropropionamide
iodoacetamide
-
10% inhibition at 1 mM
iodoacetate
-
no inhibition, incubated for 10 min
iodoacetate
-
kcat: 0.00325 per min with 250 mM at pH 7.0 and 25°C, remaining activity less than 2%
iodoacetate
-
78% inhibition at 1 mM
iodoacetate
-
81% of origin activity
Isopropanol
-
5% v/v, 60% inhibition; 60% decreased activity at 5% (v/v)
Isopropanol
25% (v/v), 54% inhibition
methanol
-
50% decreased activity at 5% (v/v); 5% v/v, 50% inhibition
methanol
25% (v/v), 33% inhibition
methyl 2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazole-5-carboxylate
-
-
methyl 2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazole-5-carboxylate
-
-
methyl 6-[2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazol-5-yl]pyridine-2-carboxylate
-
-
methyl 6-[2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazol-5-yl]pyridine-2-carboxylate
-
-
Mg2+
-
-
Mg2+
-
relative activity 91.7%, incubated for 10 min
Mg2+
-
53% inhibition at 1 mM
Mg2+
-
1-linear competitive inhibition of the amidase activity
Mg2+
-
10% inhibition at 1 mM
Mg2+
-
partially inhibited
Mn2+
-
-
Mn2+
-
12% inhibition at 1 mM
N-(cyclohexylcarbonyl)pentadecylamine
-
N-(cyclohexylcarbonyl)pentadecylamine
-
N-(cyclohexylcarbonyl)pentadecylamine
-
N-[(3S)-2-oxooxetan-3-yl]biphenyl-4-carboxamide
-
-
N-[(3S)-2-oxooxetan-3-yl]biphenyl-4-carboxamide
-
-
N-[(3S)-2-oxooxetan-3-yl]naphthalene-2-carboxamide
-
-
N-[(3S)-2-oxooxetan-3-yl]naphthalene-2-carboxamide
-
-
N-[(benzyloxy)carbonyl]-D-serine
-
weak inhibition
N-[(benzyloxy)carbonyl]-D-serine
-
weak inhibition
N-[(benzyloxy)carbonyl]-L-serine
-
weak inhibition
N-[(benzyloxy)carbonyl]-L-serine
-
weak inhibition
Na+
-
17% inhibition at 1 mM
Na+
-
1-linear competitive inhibition of the amidase activity
Ni2+
-
-
Ni2+
-
56% inhibition at 1 mM
Ni2+
10 mM, 31% inhibition
p-hydroxymercuribenzoate
-
-
p-hydroxymercuribenzoate
-
inhibition at 10 mM, inhibits the C-amidase
p-hydroxymercuribenzoate
-
53% of origin activity
Pb2+
-
-
Pb2+
-
8% inhibition at 1 mM
PCMB
-
phenyl 6-[[(3S)-2-oxooxetan-3-yl]carbamoyl]naphthalene-2-carboxylate
-
-
phenyl 6-[[(3S)-2-oxooxetan-3-yl]carbamoyl]naphthalene-2-carboxylate
-
-
phenylmethanesulfonyl fluoride
-
-
phenylmethanesulfonyl fluoride
inhibits amide conversion more than 94% and completely suppresses nitrile hydrolysis
PMSF
-
87.5% inhibition at 1 mM
URB597
-
Urea
-
47% inhibition at 1 mM
Urea
-
competitive inhibitor at pH 7.2, 90 mM acetamide protectes AI3 amidase against 2.9 mM urea over 2 h, Ki of strain AI3 is 6.6 mM, Ki of strain AIU1N is 41.3 mM and Ki of strain OUCH4 is not known, regaines full activity within 24 h at 37°C in 0.05 M Tris buffer at pH 7.2
Urea
-
competitive inhibitor at pH 7.2, 90 mM acetamide protectes AI3 amidase against 2.9 mM urea over 2 h, Ki of strain AI3 is 6.6 mM, Ki of strain AIU1N is 41.3 mM and Ki of strain OUCH4 is not known, regaines full activity within 24 h at 37°C in 0.05 M Tris buffer at pH 7.2; reversible inhibition, pH 7.2 and 37°C
Zn2+
-
89-48% residual activity at 1 mM
Zn2+
Blastobacter sp.
-
inactivates enzyme activity by 88%
Zn2+
-
relative activity 94.4%, incubated for 10 min
Zn2+
-
11% inhibition at 1 mM
Zn2+
-
7% inhibition at 1 mM
Zn2+
10 mM, 62% inhibition
additional information
-
the enzyme shows resistance to metal chelating agents EDTA, 8-hydroxyquinoline, and sodium azide and is not inhibited by DTT and PMSF or by ammonium persulfate
-
additional information
-
no inhibition by 2-mercaptoethanol and dithiotreitol; the metal ions tested show between 30% and 40% inhibition at 1 mM
-
additional information
-
cations interact with the active site via Asp189 and the S1 pocket via residue 29, no inhibition by soybean trypsin inhibitor
-
additional information
-
no inhibition with 10 mM guanidinium carbonate, 100 mM thiourea, ammonium carbamate at strain AI 3
-
additional information
-
effects of specific monoclonal antibodies on wild-type and mutant enzyme activity
-
additional information
-
no inhibition by Triton X-100, SDS, EDTA, Mn2+, and Fe3+ at 1 mM
-
additional information
-
inactivation of FAAH might affect the levels of 2-arachidonoylglycerol and, hence, the activity of CB1 receptors
-
additional information
-
N-(2-oxo-3-oxetanyl)carbamic acid esters as N-acylethanolamine acid amidase inhibitors, synthesis and structure-activity and structure-property relationships, overview. The beta-lactone ring is responsible for inhibition and and low compound stability. The compounds inhibit NAAA with a rapid, noncompetitive, and reversible mechanism, consistent with the acylation of the catalytic Cys131
-
additional information
-
N-(2-oxo-3-oxetanyl)amide inhibitor synthesis and evaluation, overview. No inhibition by N-pentadecylcyclohexanecarboxamide
-
additional information
-
diethylphosphoroamidate shows no inhibitory activity
-
additional information
no effect by EDTA, 8-hydroxyquinoline, and 2-mercaptoethanol
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.000077
1-(1,3-oxazol-2-yl)-3-(4-phenoxyphenyl)propan-1-one
-
-
0.000025
1-(1,3-oxazol-2-yl)-3-[4-(phenoxymethyl)phenyl]propan-1-one
-
-
0.000048
1-(1,3-oxazol-2-yl)-7-phenylheptan-1-one
-
-
0.00001
1-(5-iodo-1,3-oxazol-2-yl)-3-(4-phenoxyphenyl)propan-1-one
-
-
0.000004
1-(5-iodo-1,3-oxazol-2-yl)-3-[4-(phenoxymethyl)phenyl]propan-1-one
-
-
0.000003
1-(5-iodo-1,3-oxazol-2-yl)-7-phenylheptan-1-one
-
-
0.0000043
1-(5-pyridin-2-yl-1,3-oxazol-2-yl)-7-(2-thienyl)heptan-1-one
-
-
0.0000051
1-(5-pyridin-2-yl-1,3-oxazol-2-yl)-7-(3-thienyl)heptan-1-one
-
-
0.000016
1-(5-pyridin-2-yl-1,3-oxazol-2-yl)-7-[2-(trifluoromethyl)phenyl]hept-6-yn-1-one
-
-
0.000004
1-(5-pyridin-2-yl-1,3-oxazol-2-yl)-7-[2-(trifluoromethyl)phenyl]heptan-1-one
-
-
0.00001
1-(5-pyridin-2-yl-1,3-oxazol-2-yl)-7-[3-(trifluoromethyl)phenyl]hept-6-yn-1-one
-
-
0.000001
1-(5-pyridin-2-yl-1,3-oxazol-2-yl)-7-[3-(trifluoromethyl)phenyl]heptan-1-one
-
-
0.000075
1-(5-pyridin-2-yl-1,3-oxazol-2-yl)-7-[4-(trifluoromethyl)phenyl]hept-6-yn-1-one
-
-
0.000004
1-(5-pyridin-2-yl-1,3-oxazol-2-yl)-7-[4-(trifluoromethyl)phenyl]heptan-1-one
-
-
0.000025
1-([4'-[3-(1,3-oxazol-2-yl)propyl]biphenyl-4-yl]methyl)piperidine
-
-
0.01
1-[6-(2-methyl-4,5-diphenyl-1H-imidazol-1-yl)hexyl]-3-phenylurea
-
-
0.000022
11-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)undecan-1-one
-
-
0.000024
2,6-difluorophenyl [6-[4,5-bis(4-fluorophenyl)-2-methyl-1H-imidazol-1-yl]hexyl]carbamate
-
-
0.0000002
2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazole-5-carbonitrile
-
-
0.0000035
2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazole-5-carboxamide
-
-
0.00001
2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazole-5-carboxylic acid
-
-
0.000003
2-(3-biphenyl-4-ylpropanoyl)-N,N-dimethyl-1,3-oxazole-5-carboxamide
-
-
0.00006
2-(4-phenylbutoxy)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)ethanone
-
-
0.0000004
2-(7-phenylheptanoyl)-1,3-oxazole-5-carbonitrile
-
-
0.000005
2-(7-phenylheptanoyl)-1,3-oxazole-5-carboxamide
-
-
0.00003
2-(7-phenylheptanoyl)-1,3-oxazole-5-carboxylic acid
-
-
0.0008
2-chloro-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)ethanone
-
-
0.00003
2-fluorophenyl [1-ethyl-6-(2-methyl-4,5-diphenyl-1H-imidazol-1-yl)hexyl]carbamate
-
-
0.0000042
2-fluorophenyl [1-methyl-6-(2-methyl-4,5-diphenyl-1H-imidazol-1-yl)hexyl]carbamate
-
-
0.00025
2-fluorophenyl [6-(2-methyl-4,5-diphenyl-1H-imidazol-1-yl)-1-(1-methylethyl)hexyl]carbamate
-
-
0.00011
2-fluorophenyl [6-(2-methyl-4,5-diphenyl-1H-imidazol-1-yl)-1-phenylhexyl]carbamate
-
-
0.000002
2-fluorophenyl [6-(2-methyl-4,5-diphenyl-1H-imidazol-1-yl)hexyl]carbamate
-
-
0.00001
2-fluorophenyl [6-[4,5-bis(4-fluorophenyl)-2-methyl-1H-imidazol-1-yl]hexyl]carbamate
-
-
0.000008
2-hydroxy-7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.001
2-[(4-phenylbutyl)sulfinyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)ethanone
-
-
0.02
2-[(4-phenylbutyl)sulfonyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)ethanone
-
-
0.000004
2-[(4-phenylbutyl)thio]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)ethanone
-
-
0.0000008 - 0.00000085
2-[3-(4-phenoxyphenyl)propanoyl]-1,3-oxazole-5-carbonitrile
0.0000066
2-[3-(4-phenoxyphenyl)propanoyl]-1,3-oxazole-5-carboxamide
-
-
0.000041
2-[3-(4-phenoxyphenyl)propanoyl]-1,3-oxazole-5-carboxylic acid
-
-
0.0021
2-[3-(benzyloxy)phenoxy]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)ethanone
-
-
0.0000005 - 0.00000051
2-[3-[4-(phenoxymethyl)phenyl]propanoyl]-1,3-oxazole-5-carbonitrile
0.0000045
2-[3-[4-(phenoxymethyl)phenyl]propanoyl]-1,3-oxazole-5-carboxamide
-
-
0.000022
2-[3-[4-(phenoxymethyl)phenyl]propanoyl]-1,3-oxazole-5-carboxylic acid
-
-
0.0053
2-[4-(benzyloxy)phenoxy]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)ethanone
-
-
0.002
2-[methyl(4-phenylbutyl)amino]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)ethanol
-
-
0.00000075
3-(2-naphthyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
0.00009
3-(3-phenylpropoxy)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
0.000002
3-(4-anilinophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
0.0000032
3-(4-benzylphenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
0.0000034
3-(4-phenoxyphenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
0.000001 - 0.000002
3-(4-phenoxyphenyl)-1-[5-(trifluoromethyl)-1,3-oxazol-2-yl]propan-1-one
0.000016
3-biphenyl-4-yl-1-(1,3-oxazol-2-yl)propan-1-one
-
-
0.000004
3-biphenyl-4-yl-1-(5-iodo-1,3-oxazol-2-yl)propan-1-one
-
-
0.00000075 - 0.0000029
3-biphenyl-4-yl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
0.0000011
3-biphenyl-4-yl-1-(5-pyridin-3-yl-1,3-oxazol-2-yl)propan-1-one
-
-
0.0000023
3-biphenyl-4-yl-1-(5-pyridin-4-yl-1,3-oxazol-2-yl)propan-1-one
-
-
0.000003
3-biphenyl-4-yl-1-[5-(methylthio)-1,3-oxazol-2-yl]propan-1-one
-
-
0.000008
3-biphenyl-4-yl-1-[5-(trifluoroacetyl)-1,3-oxazol-2-yl]propan-1-one
-
-
0.0000007
3-biphenyl-4-yl-1-[5-(trifluoromethyl)-1,3-oxazol-2-yl]propan-1-one
-
-
0.000025
3-biphenyl-4-yl-1-[5-[6-(1H-tetrazol-1-yl)pyridin-2-yl]-1,3-oxazol-2-yl]propan-1-one
-
-
0.000035
3-hydroxy-7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.000025
3-[3-(benzyloxy)phenyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
0.00000038
3-[4-(benzyloxy)cyclohexa-1,5-dien-1-yl]-1-[1,3]oxazolo[4,5-b]pyridin-2-ylpropan-1-one
-
-
0.00000045 - 0.0000013
3-[4-(benzyloxy)phenyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
0.000001 - 0.000005
3-[4-(phenoxymethyl)phenyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
0.00000067 - 0.0000008
3-[4-(phenoxymethyl)phenyl]-1-[5-(trifluoromethyl)-1,3-oxazol-2-yl]propan-1-one
0.000021
3-[4-(phenoxymethyl)phenyl]-1-[5-[6-(1H-tetrazol-5-yl)pyridin-2-yl]-1,3-oxazol-2-yl]propan-1-one
-
-
0.0000022
3-[4-(phenylthio)phenyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
0.000001 - 0.000005
3-[4-[hydroxy(phenyl)methyl]cyclohexa-1,5-dien-1-yl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
0.000001
3-[4-[hydroxy(phenyl)methyl]phenyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
0.0002
3-[methyl(3-phenylpropyl)amino]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
0.000063
4-(2-phenylethoxy)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)butan-1-one
-
-
0.0005
4-hydroxy-7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.00012
4-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)butan-1-one
-
-
0.00005
4-[2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazol-5-yl]pyridine-2-carboxylic acid
-
-
0.0035
4-[methyl(2-phenylethyl)amino]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)butan-1-one
-
-
0.000055
5-(benzyloxy)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)pentan-1-one
-
-
0.0025
5-(benzylsulfinyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)pentan-1-one
-
-
0.0000006 - 0.000025
5-(benzylthio)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)pentan-1-one
0.0015
5-hydroxy-7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.000033
5-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)pentan-1-one
-
-
0.000044
5-[2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazol-5-yl]pyridine-2-carboxylic acid
-
-
0.0000029 - 0.0002
5-[benzyl(methyl)amino]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)pentan-1-one
0.00015
6-(2-[3-[4'-(morpholin-4-ylmethyl)biphenyl-4-yl]propyl]-1,3-oxazol-5-yl)pyridine-2-carboxylic acid
-
-
0.000033
6-(2-[3-[4'-(piperidin-1-ylmethyl)biphenyl-4-yl]propyl]-1,3-oxazol-5-yl)pyridine-2-carboxylic acid
-
-
0.00013
6-(2-[3-[4'-(pyrrolidin-1-ylmethyl)biphenyl-4-yl]propyl]-1,3-oxazol-5-yl)pyridine-2-carboxylic acid
-
-
0.000028
6-(2-[3-[4'-(thiomorpholin-4-ylmethyl)biphenyl-4-yl]propyl]-1,3-oxazol-5-yl)pyridine-2-carboxylic acid
-
-
0.0000003
6-(2-[3-[4-(phenoxymethyl)phenyl]propanoyl]-1,3-oxazol-5-yl)pyridine-2-carbonitrile
-
-
0.000006
6-(2-[3-[4-(phenoxymethyl)phenyl]propanoyl]-1,3-oxazol-5-yl)pyridine-2-carboxylic acid
-
-
0.0000046
6-(2-[3-[4-(phenoxymethyl)phenyl]propanoyl]-1,3-oxazol-5-yl)pyridine-3-carboxylic acid
-
-
0.011
6-(2-[3-[4-(piperidin-4-yloxy)phenyl]propyl]-1,3-oxazol-5-yl)pyridine-2-carboxylic acid
-
-
0.001
6-(phenylsulfinyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hexan-1-one
-
-
0.006
6-(phenylsulfonyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hexan-1-one
-
-
0.000003
6-(phenylthio)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hexan-1-one
-
-
0.0002
6-hydroxy-7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.0031
6-oxo-N-phenyl-6-(5-pyridin-2-yl-1,3-oxazol-2-yl)hexanamide
-
-
0.000014
6-phenoxy-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hexan-1-one
-
-
0.000011
6-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hexan-1-one
-
-
0.01
6-[2-(3-biphenyl-4-yl-1-hydroxypropyl)-1,3-oxazol-5-yl]nicotinic acid
-
-
0.02
6-[2-(3-biphenyl-4-yl-1-hydroxypropyl)-1,3-oxazol-5-yl]pyridine-2-carboxamide
-
-
0.0011
6-[2-(3-biphenyl-4-yl-1-hydroxypropyl)-1,3-oxazol-5-yl]pyridine-2-carboxylic acid
-
-
0.0000013
6-[2-(3-biphenyl-4-yl-1-hydroxypropyl)-1,3-oxazol-5-yl]pyridine-3-carboxamide
-
-
0.0000013
6-[2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazol-5-yl]nicotinamide
-
-
0.000014
6-[2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazol-5-yl]nicotinic acid
-
-
0.0000029
6-[2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazol-5-yl]pyridine-2-carbonitrile
-
-
0.0000012
6-[2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazol-5-yl]pyridine-2-carboxamide
-
-
0.000022
6-[2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazol-5-yl]pyridine-2-carboxylic acid
-
-
0.03
6-[2-(3-biphenyl-4-ylpropyl)-1,3-oxazol-5-yl]nicotinamide
-
-
0.02
6-[2-(3-biphenyl-4-ylpropyl)-1,3-oxazol-5-yl]nicotinic acid
-
-
0.004
6-[2-(3-biphenyl-4-ylpropyl)-1,3-oxazol-5-yl]pyridine-2-carboxamide
-
-
0.01
6-[2-(3-biphenyl-4-ylpropyl)-1,3-oxazol-5-yl]pyridine-2-carboxylic acid
-
-
0.0012
6-[2-(3-[4'-[(4-aminopiperazin-1-yl)methyl]biphenyl-4-yl]propyl)-1,3-oxazol-5-yl]pyridine-2-carboxylic acid
-
-
0.000007
6-[2-(7-phenylheptanoyl)-1,3-oxazol-5-yl]nicotinic acid
-
-
0.0000029
6-[2-(7-phenylheptanoyl)-1,3-oxazol-5-yl]pyridine-2-carbonitrile
-
-
0.00002
6-[2-(7-phenylheptanoyl)-1,3-oxazol-5-yl]pyridine-2-carboxylic acid
-
-
0.000033
6-[2-[3-(4-phenoxyphenyl)propanoyl]-1,3-oxazol-5-yl]nicotinic acid
-
-
0.000065
6-[2-[3-(4-phenoxyphenyl)propanoyl]-1,3-oxazol-5-yl]pyridine-2-carboxylic acid
-
-
0.00012
6-[2-[3-(4-[[1-(tert-butoxycarbonyl)piperidin-4-yl]oxy]phenyl)propyl]-1,3-oxazol-5-yl]pyridine-2-carboxylic acid
-
-
0.00004
6-[methyl(phenyl)amino]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hexan-1-one
-
-
0.000005
7-(2,3-dichlorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one
-
-
0.0000009 - 0.0000012
7-(2,3-dichlorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
0.000013
7-(2-chlorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one
-
-
0.0000019
7-(2-chlorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.000008
7-(2-fluorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one
-
-
0.0000017
7-(2-fluorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.0000058
7-(2-methoxyphenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.000003
7-(2-methylphenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.000017
7-(2-nitrophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one
-
-
0.00003
7-(3-aminophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.000007
7-(3-chlorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one
-
-
0.0000009
7-(3-chlorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.0000032
7-(3-fluorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one
-
-
0.0000022
7-(3-fluorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.0000025
7-(3-methoxyphenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.0000033
7-(3-methylphenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.00000048
7-(3-nitrophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one
-
-
0.000003
7-(4-aminophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.00002
7-(4-chlorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one
-
-
0.000027
7-(4-chlorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.000036
7-(4-fluorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one
-
-
0.0000032
7-(4-fluorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.0000062
7-(4-methoxyphenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.0000028
7-(4-methylphenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.000031
7-(4-nitrophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one
-
-
0.0000065
7-(4-nitrophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.000035
7-hydroxy-7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.0000026
7-naphthalen-1-yl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.000011
7-naphthalen-2-yl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.000025
7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one
-
-
0.0000047
7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.0000008
7-phenyl-1-[5-(trifluoromethyl)-1,3-oxazol-2-yl]heptan-1-one
-
-
0.00004
7-phenyl-1-[5-[6-(1H-tetrazol-5-yl)pyridin-2-yl]-1,3-oxazol-2-yl]heptan-1-one
-
-
0.00028
7-pyridin-2-yl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one
-
-
0.00012
7-pyridin-2-yl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.0003
7-pyridin-3-yl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one
-
-
0.000032
7-pyridin-3-yl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.00015
7-pyridin-4-yl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-6-yn-1-one
-
-
0.0000033
7-[2-(methylsulfanyl)phenyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.0000042
7-[3-(methylsulfanyl)phenyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.0000024
7-[3-(tert-butylamino)phenyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.0000025
7-[4-(methylsulfanyl)phenyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.0000056
7-[4-(tert-butylamino)phenyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.0000075
8-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)octan-1-one
-
-
0.000008
9-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)nonan-1-one
-
-
0.005 - 0.0051
acetaldehyde
0.007
acetaldehyde ammonia
-
strain AI3
0.0014
acetanilide
-
substrate 4-nitroacetanilide, competitive inhibition
0.001
Chloroacetone
-
pH 7.1, 25°C, irreversible
0.0008
cyclopentyl(5-pyridin-2-yl-1,3-oxazol-2-yl)methanone
-
-
0.0025
cyclopropyl(5-pyridin-2-yl-1,3-oxazol-2-yl)methanone
-
-
0.000091
ethyl 4-[3-(4,5-diphenyl-1H-imidazol-1-yl)phenoxy]butanoate
-
-
0.000064
ethyl 4-[4-(4,5-diphenyl-1H-imidazol-1-yl)phenoxy]butanoate
-
-
0.000032
ethyl 6-(2-ethyl-4,5-diphenyl-1H-imidazol-1-yl)hexanoate
-
-
0.000003
ethyl 6-[2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazol-5-yl]pyridine-2-carboxylate
-
-
0.000011
ethyl 7-(2-ethyl-4,5-diphenyl-1H-imidazol-1-yl)heptanoate
-
-
0.000064
ethyl 7-[4,5-bis(4-fluorophenyl)-2-methyl-1H-imidazol-1-yl]heptanoate
-
-
0.000031
ethyl 8-(2-ethyl-4,5-diphenyl-1H-imidazol-1-yl)octanoate
-
-
0.00000026 - 0.0000015
methyl 2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazole-5-carboxylate
0.0000012
methyl 2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazole-5-sulfinate
-
-
0.0000009
methyl 2-(7-phenylheptanoyl)-1,3-oxazole-5-carboxylate
-
-
0.0000017
methyl 2-[3-(4-phenoxyphenyl)propanoyl]-1,3-oxazole-5-carboxylate
-
-
0.0000016
methyl 2-[3-[4-(phenoxymethyl)phenyl]propanoyl]-1,3-oxazole-5-carboxylate
-
-
0.000034
methyl 2-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-1-yn-1-yl]benzoate
-
-
0.000037
methyl 2-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptyl]benzenesulfinate
-
-
0.000001
methyl 2-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptyl]benzoate
-
-
0.00003
methyl 3-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-1-yn-1-yl]benzoate
-
-
0.0000013
methyl 3-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptyl]benzenesulfinate
-
-
0.0000019
methyl 3-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptyl]benzoate
-
-
0.0000015
methyl 4-[2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazol-5-yl]pyridine-2-carboxylate
-
-
0.000025
methyl 4-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-1-yn-1-yl]benzoate
-
-
0.000019
methyl 4-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptyl]benzenesulfinate
-
-
0.0000015
methyl 4-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptyl]benzoate
-
-
0.007
methyl 5-oxo-5-(5-pyridin-2-yl-1,3-oxazol-2-yl)pentanoate
-
-
0.0000006
methyl 5-[2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazol-5-yl]pyridine-2-carboxylate
-
-
0.000031
methyl 6-(2-[3-[4'-(morpholin-4-ylmethyl)biphenyl-4-yl]propyl]-1,3-oxazol-5-yl)pyridine-2-carboxylate
-
-
0.000009
methyl 6-(2-[3-[4'-(piperidin-1-ylmethyl)biphenyl-4-yl]propyl]-1,3-oxazol-5-yl)pyridine-2-carboxylate
-
-
0.000018
methyl 6-(2-[3-[4'-(pyrrolidin-1-ylmethyl)biphenyl-4-yl]propyl]-1,3-oxazol-5-yl)pyridine-2-carboxylate
-
-
0.000005
methyl 6-(2-[3-[4'-(thiomorpholin-4-ylmethyl)biphenyl-4-yl]propyl]-1,3-oxazol-5-yl)pyridine-2-carboxylate
-
-
0.000002
methyl 6-(2-[3-[4-(phenoxymethyl)phenyl]propanoyl]-1,3-oxazol-5-yl)pyridine-2-carboxylate
-
-
0.0000035
methyl 6-(2-[3-[4-(phenoxymethyl)phenyl]propanoyl]-1,3-oxazol-5-yl)pyridine-3-carboxylate
-
-
0.0045
methyl 6-(2-[3-[4-(piperidin-4-yloxy)phenyl]propyl]-1,3-oxazol-5-yl)pyridine-2-carboxylate
-
-
0.0018
methyl 6-oxo-6-(5-pyridin-2-yl-1,3-oxazol-2-yl)hexanoate
-
-
0.009
methyl 6-[2-(3-biphenyl-4-yl-1-hydroxypropyl)-1,3-oxazol-5-yl]pyridine-2-carboxylate
-
-
0.0011
methyl 6-[2-(3-biphenyl-4-yl-1-hydroxypropyl)-1,3-oxazol-5-yl]pyridine-3-carboxylate
-
-
0.0000012
methyl 6-[2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazol-5-yl]pyridine-2-carboxylate
0.0000022
methyl 6-[2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazol-5-yl]pyridine-3-carboxylate
-
-
0.007
methyl 6-[2-(3-biphenyl-4-ylpropyl)-1,3-oxazol-5-yl]pyridine-2-carboxylate
-
-
0.05
methyl 6-[2-(3-biphenyl-4-ylpropyl)-1,3-oxazol-5-yl]pyridine-3-carboxylate
-
-
0.000029
methyl 6-[2-(3-[4'-[(dimethylamino)methyl]biphenyl-4-yl]propyl)-1,3-oxazol-5-yl]pyridine-2-carboxylate
-
-
0.000008
methyl 6-[2-(7-phenylheptanoyl)-1,3-oxazol-5-yl]pyridine-2-carboxylate
-
-
0.0000035
methyl 6-[2-(7-phenylheptanoyl)-1,3-oxazol-5-yl]pyridine-3-carboxylate
-
-
0.000013
methyl 6-[2-[3-(4-phenoxyphenyl)propanoyl]-1,3-oxazol-5-yl]pyridine-2-carboxylate
-
-
0.000054
methyl 6-[2-[3-(4-phenoxyphenyl)propanoyl]-1,3-oxazol-5-yl]pyridine-3-carboxylate
-
-
0.000032
methyl 6-[2-[3-(4-[[1-(tert-butoxycarbonyl)piperidin-4-yl]oxy]phenyl)propyl]-1,3-oxazol-5-yl]pyridine-2-carboxylate
-
-
0.0065
methyl [3-(4,5-diphenyl-1H-imidazol-1-yl)phenoxy]acetate
-
-
0.00067
methyl [4-(4,5-diphenyl-1H-imidazol-1-yl)phenoxy]acetate
-
-
0.000002
N,N-dimethyl-2-(7-phenylheptanoyl)-1,3-oxazole-5-carboxamide
-
-
0.0000054
N,N-dimethyl-2-[3-(4-phenoxyphenyl)propanoyl]-1,3-oxazole-5-carboxamide
-
-
0.0000067
N,N-dimethyl-2-[3-[4-(phenoxymethyl)phenyl]propanoyl]-1,3-oxazole-5-carboxamide
-
-
0.00097
N,N-dimethyl-7-(2-methyl-4,5-diphenyl-1H-imidazol-1-yl)heptanamide
-
-
0.02
N-benzyl-5-oxo-5-(5-pyridin-2-yl-1,3-oxazol-2-yl)pentanamide
-
-
0.000007
N-methyl-2-(7-phenylheptanoyl)-1,3-oxazole-5-carboxamide
-
-
0.000011
N-methyl-2-[3-(4-phenoxyphenyl)propanoyl]-1,3-oxazole-5-carboxamide
-
-
0.0000036
N-methyl-2-[3-[4-(phenoxymethyl)phenyl]propanoyl]-1,3-oxazole-5-carboxamide
-
-
0.0017
N-methyl-7-(2-methyl-4,5-diphenyl-1H-imidazol-1-yl)heptanamide
-
-
0.0000089
Phenacetin
-
substrate 4-nitroacetanilide, competitive inhibition, induction of activity for 2-nitrophenylacetate and methylbutyrate
0.0000016
phenyl [6-(2-methyl-4,5-diphenyl-1H-imidazol-1-yl)hexyl]carbamate
-
-
0.000012
tert-butyl [3-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-1-yn-1-yl]phenyl]carbamate
-
-
0.000023
tert-butyl [4-[7-oxo-7-(5-pyridin-2-yl-1,3-oxazol-2-yl)hept-1-yn-1-yl]phenyl]carbamate
-
-
additional information
additional information
-
inhibition kinetics
-
0.0000008
2-[3-(4-phenoxyphenyl)propanoyl]-1,3-oxazole-5-carbonitrile
-
-
0.00000085
2-[3-(4-phenoxyphenyl)propanoyl]-1,3-oxazole-5-carbonitrile
-
-
0.0000005
2-[3-[4-(phenoxymethyl)phenyl]propanoyl]-1,3-oxazole-5-carbonitrile
-
-
0.00000051
2-[3-[4-(phenoxymethyl)phenyl]propanoyl]-1,3-oxazole-5-carbonitrile
-
-
0.000001
3-(4-phenoxyphenyl)-1-[5-(trifluoromethyl)-1,3-oxazol-2-yl]propan-1-one
-
-
0.000002
3-(4-phenoxyphenyl)-1-[5-(trifluoromethyl)-1,3-oxazol-2-yl]propan-1-one
-
-
0.00000075
3-biphenyl-4-yl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
0.0000029
3-biphenyl-4-yl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
0.00000045
3-[4-(benzyloxy)phenyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
0.0000013
3-[4-(benzyloxy)phenyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
0.000001
3-[4-(phenoxymethyl)phenyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
0.000005
3-[4-(phenoxymethyl)phenyl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
0.00000067
3-[4-(phenoxymethyl)phenyl]-1-[5-(trifluoromethyl)-1,3-oxazol-2-yl]propan-1-one
-
-
0.0000008
3-[4-(phenoxymethyl)phenyl]-1-[5-(trifluoromethyl)-1,3-oxazol-2-yl]propan-1-one
-
-
0.000001
3-[4-[hydroxy(phenyl)methyl]cyclohexa-1,5-dien-1-yl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
0.000005
3-[4-[hydroxy(phenyl)methyl]cyclohexa-1,5-dien-1-yl]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)propan-1-one
-
-
0.0000006
5-(benzylthio)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)pentan-1-one
-
-
0.000025
5-(benzylthio)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)pentan-1-one
-
-
0.0000029
5-[benzyl(methyl)amino]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)pentan-1-one
-
-
0.0002
5-[benzyl(methyl)amino]-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)pentan-1-one
-
-
0.0000009
7-(2,3-dichlorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.0000012
7-(2,3-dichlorophenyl)-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
-
-
0.005
acetaldehyde
-
strain AI3
0.0051
acetaldehyde
-
competitive inhibitor
12.1
acetamide
-
pH 7.2
12.1
acetamide
-
at pH 7 and 50°C
2.3
Acrylamide
-
pH 7.2
2.3
Acrylamide
-
at pH 7 and 50°C
1.1
Cyanate
-
strain AI3, pH 7.2 and 37°C
1.8
Cyanate
-
strain AIU1N, pH 7.2 and 37°C
50
Cyanate
-
strain OUCH4, pH 7.2 and 37°C
1.4
Hydroxyurea
-
strain AI3, pH 7.2 and 37°C
10.8
Hydroxyurea
-
strain AIU1N, pH 7.2 and 37°C
337
Hydroxyurea
-
strain OUCH4, pH 7.2 and 37°C
0.00000026
methyl 2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazole-5-carboxylate
-
-
0.0000015
methyl 2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazole-5-carboxylate
-
-
0.0000012
methyl 6-[2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazol-5-yl]pyridine-2-carboxylate
-
-
0.0000012
methyl 6-[2-(3-biphenyl-4-ylpropanoyl)-1,3-oxazol-5-yl]pyridine-2-carboxylate
-
-
6.6
Urea
-
strain AI3, pH 7.2 and 37°C
41.3
Urea
-
strain AIU1N pH 7.2 and 37°C
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.09
(+/-)-(5Z,8Z,11Z,14Z)-N-((2,2-dimethyl-1,3-dioxolan-4-yl)methyl)icosa-5,8,11,14-tetraenamide
Rattus norvegicus
-
-
0.098
(+/-)-2,2-dimethyl-1,3-dioxolan-4-ylmethyl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate
Rattus norvegicus
-
-
0.012
(+/-)-oxiran-2-ylmethyl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate
Rattus norvegicus
-
-
0.0082
(+/-)-oxiran-2-ylmethyl (9Z)-hexadec-9-enoate
Rattus norvegicus
-
-
0.011
(+/-)-oxiran-2-ylmethyl (9Z)-octadec-9-enoate
Rattus norvegicus
-
-
0.01
(+/-)-oxiran-2-ylmethyl (9Z,12Z)-octadeca-9,12-dienoate
Rattus norvegicus
-
-
0.0016
(+/-)-oxiran-2-ylmethyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
Rattus norvegicus
-
-
0.061
(+/-)-oxiran-2-ylmethyl 1,1'-biphenyl-3-carboxylate
Rattus norvegicus
-
-
0.035
(+/-)-oxiran-2-ylmethyl 1,1'-biphenyl-4-carboxylate
Rattus norvegicus
-
-
0.051
(+/-)-tetrahydro-2H-pyran-2-ylmethyl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate
Rattus norvegicus
-
-
0.01
(+/-)-tetrahydro-2H-pyran-2-ylmethyl (9Z)-hexadec-9-enoate
Rattus norvegicus
-
-
0.029
(+/-)-tetrahydro-2H-pyran-2-ylmethyl (9Z)-octadec-9-enoate
Rattus norvegicus
-
-
0.0075
(+/-)-tetrahydro-2H-pyran-2-ylmethyl (9Z,12Z)-octadeca-9,12-dienoate
Rattus norvegicus
-
-
0.019
(+/-)-tetrahydro-2H-pyran-2-ylmethyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
Rattus norvegicus
-
-
0.043
(+/-)-tetrahydro-2H-pyran-2-ylmethyl 1,1'-biphenyl-2-carboxylate
Rattus norvegicus
-
-
0.018
(+/-)-tetrahydro-2H-pyran-2-ylmethyl 1,1'-biphenyl-3-carboxylate
Rattus norvegicus
-
-
0.032
(+/-)-tetrahydro-2H-pyran-2-ylmethyl 1,1'-biphenyl-4-carboxylate
Rattus norvegicus
-
-
0.053
(+/-)-tetrahydro-2H-pyran-2-ylmethyl benzoate
Rattus norvegicus
-
-
0.0049
(2R,3R)-allo-2-methyl-4-oxo-3-oxetanylcarbamic acid tert-butyl ester
0.1
(2R,3S)-2-methyl-4-oxo-3-oxetanylcarbamic acid benzyl ester
0.08
(2R,3S)-2-methyl-4-oxo-3-oxetanylcarbamic acid tert-butyl ester
0.000127
(2S,3R)-2-methyl-4-oxo-3-oxetanylcarbamic acid 5-phenylpentyl ester
0.001
(2S,3R)-2-methyl-4-oxo-3-oxetanylcarbamic acid benzyl ester
0.00022
(2S,3R)-2-methyl-4-oxo-3-oxetanylcarbamic acid tert-butyl ester
0.00019
(2S,3S)-allo-2-methyl-4-oxo-3-oxetanylcarbamic acid tert-butyl ester
0.01
(5Z,8Z,11Z,14Z)-eicosantetraenoic acid 3-thienyl methyl ester
Rattus norvegicus
-
i.e. CAY-10402, IC50: 0.010 mM, 37% inhibition at 0.1 mM
0.0005
(R)-(2-oxo-3-oxetanyl)carbamic acid tert-butyl ester
0.0492
(R)-1-methyl-3-(2-oxo-3-oxetanyl)urea
0.0007
(R)-2-oxo-3-oxetanylcarbamic acid benzyl ester
0.1
(R,S)-2-oxocyclobutylcarbamic acid benzyl ester
0.00058
(S)-(2-oxo-3-oxetanyl)carbamic acid tert-butyl ester
0.015
(S)-1-methyl-3-(2-oxo-3-oxetanyl)urea
0.00296
(S)-2-oxo-3-oxetanylcarbamic acid benzyl ester
0.091
1,3-benzodioxol-5-ylmethyl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate
Rattus norvegicus
-
-
0.0057
1-(1,3-oxazol-2-yl)-4-piperidin-4-ylbutan-1-one
Homo sapiens
-
-
0.000022
1-(1,3-oxazol-2-yl)-4-[1-(3-phenylpropanoyl)piperidin-4-yl]butan-1-one
Homo sapiens
-
-
0.0005
1-(1,3-oxazol-2-yl)-4-[1-(phenylacetyl)piperidin-4-yl]butan-1-one
Homo sapiens
-
-
0.0000025
1-(1,3-oxazol-2-yl)-4-[1-(phenylsulfonyl)piperidin-4-yl]butan-1-one
Homo sapiens
-
-
0.000006
1-(1,3-oxazol-2-yl)-4-[1-[(2-phenylethyl)sulfonyl]piperidin-4-yl]butan-1-one
Homo sapiens
-
-
0.0062
1-arachidonoylglycerol
Rattus norvegicus
-
IC50: 0.0062 mM
0.018
1-myristin
Rattus norvegicus
-
IC50: 0.018 mM, complete inhibition is possible
0.008
1-palmitin
Rattus norvegicus
-
IC50: 0.0080 mM, complete inhibition is possible
0.01
2,3-dihydroxypropyl (11Z)-icos-11-enoate
Rattus norvegicus
-
i.e. O-4066, IC50: 0.010 mM, complete inhibition is possible
0.0057
2,3-dihydroxypropyl (11Z,14Z)-icosa-11,14-dienoate
Rattus norvegicus
-
i.e. O-3907, IC50: 0.0057 mM, complete inhibition is possible
0.011
2,3-dihydroxypropyl (5Z)-icos-5-enoate
Rattus norvegicus
-
i.e. O-3908, IC50: 0.011 mM, 84% inhibition is possible
0.0024
2,3-dihydroxypropyl (5Z,8Z,11Z)-2-ethylcycloheptadeca-5,8,11-triene-1-carboxylate
Rattus norvegicus
-
i.e. O-3973, IC50: 0.0024, 95% inhibition is possible
0.0076
2,3-dihydroxypropyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
Rattus norvegicus
-
i.e. O-3832, IC50: 0.0076 mM, complete inhibition is possible
0.0051
2,3-dihydroxypropyl (6Z,9Z,12Z,15Z)-cyclohenicosa-6,9,12,15-tetraene-1-carboxylate
Rattus norvegicus
-
i.e. O-4081, IC50: 0.0051 mM, 90% inhibition is possible
0.014
2,3-dihydroxypropyl (7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoate
Rattus norvegicus
-
i.e. O-3872, IC50: 0.014, complete inhibition is possible
0.023
2,3-dihydroxypropyl (8Z,11Z,14Z)-icosa-8,11,14-trienoate
Rattus norvegicus
-
i.e. 3846, IC50: 0.023, complete inhibition is possible
0.021
2-(5,5-dimethyl-1,3-dioxan-2-yl)ethyl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate
Rattus norvegicus
-
-
0.000002
2-fluorophenyl [6-(2-methyl-4,5-diphenyl-1H-imidazol-1-yl)hexyl]carbamate
Rattus norvegicus
-
-
0.00000038 - 0.000001
3'-carbamoylbiphenyl-3-yl undec-10-yn-1-ylcarbamate
0.000077
4-(1-benzoylpiperidin-4-yl)-1-(1,3-oxazol-2-yl)butan-1-one
Homo sapiens
-
-
0.000315
4-(1-benzylpiperidin-4-yl)-1-(1,3-oxazol-2-yl)butan-1-one
Homo sapiens
-
-
0.000283 - 0.00136
4-(benzyloxy)phenyl butylcarbamate
0.000315
4-[1-(2-bromobenzyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
Homo sapiens
-
-
0.00026
4-[1-(2-chlorobenzyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
Homo sapiens
-
-
0.004
4-[1-(2-methoxybenzyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
Homo sapiens
-
-
0.0012
4-[1-(2-methylbenzyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
Homo sapiens
-
-
0.00009
4-[1-(3,3-dimethylbutanoyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
Homo sapiens
-
-
0.00001
4-[1-(3-bromobenzyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
Homo sapiens
-
-
0.00006
4-[1-(3-chlorobenzyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
Homo sapiens
-
-
0.000003
4-[1-(3-cyclohexylpropanoyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
Homo sapiens
-
-
0.000034
4-[1-(3-methoxybenzyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
Homo sapiens
-
-
0.00009
4-[1-(3-methylbenzyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
Homo sapiens
-
-
0.000045
4-[1-(4-bromobenzyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
Homo sapiens
-
-
0.000066
4-[1-(4-chlorobenzyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
Homo sapiens
-
-
0.00013
4-[1-(4-methoxybenzyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
Homo sapiens
-
-
0.0004
4-[1-(4-methylbenzyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
Homo sapiens
-
-
0.0006
4-[1-(benzylsulfonyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
Homo sapiens
-
-
0.0001
4-[1-(cyclohexylacetyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
Homo sapiens
-
-
0.000045
4-[1-(cyclohexylcarbonyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
Homo sapiens
-
-
0.00025
4-[1-(cyclopropylcarbonyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
Homo sapiens
-
-
0.00014
4-[1-(isopropylsulfonyl)piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
Homo sapiens
-
-
0.000005
4-[1-[3-(1-methylethoxy)benzyl]piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
Homo sapiens
-
-
0.000001
4-[1-[3-(1-methylethyl)benzyl]piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
Homo sapiens
-
-
0.000014
4-[1-[4-(1-methylethoxy)benzyl]piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
Homo sapiens
-
-
0.0000036
4-[1-[4-(1-methylethyl)benzyl]piperidin-4-yl]-1-(1,3-oxazol-2-yl)butan-1-one
Homo sapiens
-
-
0.0000134 - 0.000206
7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
0.033
alpha-methyl-1-arachidonoylglycerol
Rattus norvegicus
-
IC50: 0.033 mM, complete inhibition at 0.1 mM
0.058
arachidonic acid
Rattus norvegicus
-
IC50: 0.058 mM, complete inhibition at 0.1 mM
0.0049
arachidonoyl glycine
Rattus norvegicus
-
IC50: 0.0049 mM, complete inhibition at 0.1 mM
0.078
arachidonoyl serinol
Rattus norvegicus
-
IC50: 0.078 mM, complete inhibition at 0.1 mM
0.000004
benzyl 4-[4-(1,3-oxazol-2-yl)-4-oxobutyl]piperidine-1-carboxylate
Homo sapiens
-
-
0.0000005
CAY10400
Rattus norvegicus
-
-
0.1
cyclobutylcarbamic acid benzyl ester
0.000004
isopropyl 4-[4-(1,3-oxazol-2-yl)-4-oxobutyl]piperidine-1-carboxylate
Homo sapiens
-
-
0.0026
N-(4-hydroxy-2-methylphenyl)arachidonylamide
Rattus norvegicus
-
i.e. VDM11, an anandamide uptake inhibitor, IC50 is 0.0026 mM, inhibitory potency depends upon the concentration of bovine serum albumin
0.0021
N-(4-hydroxyphenyl)arachidonylamide
Rattus norvegicus
-
i.e. AM404, an anandamide uptake inhibitor, IC50 is 0.0021 mM
0.000115
N-[(3S)-2-oxooxetan-3-yl]biphenyl-4-carboxamide
0.1
N-[(benzyloxy)carbonyl]-D-serine
0.1
N-[(benzyloxy)carbonyl]-L-serine
0.003
noladin ether
Rattus norvegicus
-
IC50: 0.003 mM, complete inhibition at 0.1 mM
0.0075
pentadecylamine
Rattus norvegicus
-
pH 5.0, 37°C
0.000002
tert-butyl 4-[4-(1,3-oxazol-2-yl)-4-oxobutyl]piperidine-1-carboxylate
Homo sapiens
-
-
0.0053
tetrahydro-2H-pyran-4-yl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate
Rattus norvegicus
-
-
0.0118
tridecyl 2-aminoacetate
Rattus norvegicus
-
pH 5.0, 37°C
0.05
UCM707
Rattus norvegicus
-
-
0.000002
URB597
Rattus norvegicus
-
-
0.005
VDM11
Rattus norvegicus
-
-
0.0049
(2R,3R)-allo-2-methyl-4-oxo-3-oxetanylcarbamic acid tert-butyl ester
Rattus norvegicus
-
pH 5.0, 37°C, recombinant enzyme
0.0049
(2R,3R)-allo-2-methyl-4-oxo-3-oxetanylcarbamic acid tert-butyl ester
Pseudomonas aeruginosa
-
pH 5.0, 37°C, recombinant enzyme
0.1
(2R,3S)-2-methyl-4-oxo-3-oxetanylcarbamic acid benzyl ester
Rattus norvegicus
-
pH 5.0, 37°C, recombinant enzyme
0.1
(2R,3S)-2-methyl-4-oxo-3-oxetanylcarbamic acid benzyl ester
Pseudomonas aeruginosa
-
pH 5.0, 37°C, recombinant enzyme
0.08
(2R,3S)-2-methyl-4-oxo-3-oxetanylcarbamic acid tert-butyl ester
Rattus norvegicus
-
pH 5.0, 37°C, recombinant enzyme
0.08
(2R,3S)-2-methyl-4-oxo-3-oxetanylcarbamic acid tert-butyl ester
Pseudomonas aeruginosa
-
pH 5.0, 37°C, recombinant enzyme
0.000127
(2S,3R)-2-methyl-4-oxo-3-oxetanylcarbamic acid 5-phenylpentyl ester
Rattus norvegicus
-
pH 5.0, 37°C, recombinant enzyme
0.000127
(2S,3R)-2-methyl-4-oxo-3-oxetanylcarbamic acid 5-phenylpentyl ester
Pseudomonas aeruginosa
-
pH 5.0, 37°C, recombinant enzyme
0.001
(2S,3R)-2-methyl-4-oxo-3-oxetanylcarbamic acid benzyl ester
Rattus norvegicus
-
pH 5.0, 37°C, recombinant enzyme
0.001
(2S,3R)-2-methyl-4-oxo-3-oxetanylcarbamic acid benzyl ester
Pseudomonas aeruginosa
-
pH 5.0, 37°C, recombinant enzyme
0.00022
(2S,3R)-2-methyl-4-oxo-3-oxetanylcarbamic acid tert-butyl ester
Rattus norvegicus
-
pH 5.0, 37°C, recombinant enzyme
0.00022
(2S,3R)-2-methyl-4-oxo-3-oxetanylcarbamic acid tert-butyl ester
Pseudomonas aeruginosa
-
pH 5.0, 37°C, recombinant enzyme
0.00019
(2S,3S)-allo-2-methyl-4-oxo-3-oxetanylcarbamic acid tert-butyl ester
Rattus norvegicus
-
pH 5.0, 37°C, recombinant enzyme
0.00019
(2S,3S)-allo-2-methyl-4-oxo-3-oxetanylcarbamic acid tert-butyl ester
Pseudomonas aeruginosa
-
pH 5.0, 37°C, recombinant enzyme
0.0005
(R)-(2-oxo-3-oxetanyl)carbamic acid tert-butyl ester
Rattus norvegicus
-
pH 5.0, 37°C, recombinant enzyme
0.0005
(R)-(2-oxo-3-oxetanyl)carbamic acid tert-butyl ester
Pseudomonas aeruginosa
-
pH 5.0, 37°C, recombinant enzyme
0.0492
(R)-1-methyl-3-(2-oxo-3-oxetanyl)urea
Rattus norvegicus
-
pH 5.0, 37°C, recombinant enzyme
0.0492
(R)-1-methyl-3-(2-oxo-3-oxetanyl)urea
Pseudomonas aeruginosa
-
pH 5.0, 37°C, recombinant enzyme
0.0007
(R)-2-oxo-3-oxetanylcarbamic acid benzyl ester
Rattus norvegicus
-
pH 5.0, 37°C, recombinant enzyme
0.0007
(R)-2-oxo-3-oxetanylcarbamic acid benzyl ester
Pseudomonas aeruginosa
-
pH 5.0, 37°C, recombinant enzyme
0.1
(R,S)-2-oxocyclobutylcarbamic acid benzyl ester
Rattus norvegicus
-
pH 5.0, 37°C, recombinant enzyme
0.1
(R,S)-2-oxocyclobutylcarbamic acid benzyl ester
Pseudomonas aeruginosa
-
pH 5.0, 37°C, recombinant enzyme
0.00058
(S)-(2-oxo-3-oxetanyl)carbamic acid tert-butyl ester
Rattus norvegicus
-
pH 5.0, 37°C, recombinant enzyme
0.00058
(S)-(2-oxo-3-oxetanyl)carbamic acid tert-butyl ester
Pseudomonas aeruginosa
-
pH 5.0, 37°C, recombinant enzyme
0.015
(S)-1-methyl-3-(2-oxo-3-oxetanyl)urea
Rattus norvegicus
-
pH 5.0, 37°C, recombinant enzyme
0.015
(S)-1-methyl-3-(2-oxo-3-oxetanyl)urea
Pseudomonas aeruginosa
-
pH 5.0, 37°C, recombinant enzyme
0.00296
(S)-2-oxo-3-oxetanylcarbamic acid benzyl ester
Rattus norvegicus
-
pH 5.0, 37°C, recombinant enzyme
0.00296
(S)-2-oxo-3-oxetanylcarbamic acid benzyl ester
Pseudomonas aeruginosa
-
pH 5.0, 37°C, recombinant enzyme
0.00000038
3'-carbamoylbiphenyl-3-yl undec-10-yn-1-ylcarbamate
Homo sapiens
-
0.000001
3'-carbamoylbiphenyl-3-yl undec-10-yn-1-ylcarbamate
Homo sapiens
-
0.000283
4-(benzyloxy)phenyl butylcarbamate
Homo sapiens
-
0.00136
4-(benzyloxy)phenyl butylcarbamate
Homo sapiens
-
0.0000134
7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
Homo sapiens
-
0.000206
7-phenyl-1-(5-pyridin-2-yl-1,3-oxazol-2-yl)heptan-1-one
Homo sapiens
-
0.1
cyclobutylcarbamic acid benzyl ester
Rattus norvegicus
-
pH 5.0, 37°C, recombinant enzyme
0.1
cyclobutylcarbamic acid benzyl ester
Pseudomonas aeruginosa
-
pH 5.0, 37°C, recombinant enzyme
0.000115
N-[(3S)-2-oxooxetan-3-yl]biphenyl-4-carboxamide
Rattus norvegicus
-
pH 5.0, 37°C, recombinant enzyme
0.000115
N-[(3S)-2-oxooxetan-3-yl]biphenyl-4-carboxamide
Pseudomonas aeruginosa
-
pH 5.0, 37°C, recombinant enzyme
0.1
N-[(benzyloxy)carbonyl]-D-serine
Rattus norvegicus
-
pH 5.0, 37°C, recombinant enzyme
0.1
N-[(benzyloxy)carbonyl]-D-serine
Pseudomonas aeruginosa
-
pH 5.0, 37°C, recombinant enzyme
0.1
N-[(benzyloxy)carbonyl]-L-serine
Rattus norvegicus
-
pH 5.0, 37°C, recombinant enzyme
0.1
N-[(benzyloxy)carbonyl]-L-serine
Pseudomonas aeruginosa
-
pH 5.0, 37°C, recombinant enzyme
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.000028
-
substrate indoleacetonitrile at 30°C, activity after purification
0.00003
-
growth substrate 2-monochloropropionic acid, 2-chloropropionamide-amidase activity, measured with 80 mM 2-chloropropionamide, strain PP3
0.000031
-
substrate indole-3-acetamide at 30°C, activity after purification
0.00024
-
growth substrate succinate, 2-chloropropionamide-amidase activity, measured with 80 mM 2-chloropropionamide, strain PP3
0.00027
-
growth substrate 2-chloropropionamide, 2-chloropropionamide-amidase activity, measured with 14 mM 2-chloropropionamide, strain PP3
0.00074
-
membrane fraction
0.0017
-
growth substrate propionamide, 2-chloropropionamide-amidase activity, measured with 80 mM 2-chloropropionamide, strain PAU3
0.0021
-
D191E mutant, supernatant of cell-free extract, 0.75% of wild-type activity
0.00243
-
harboring pALJ20, substrate cyclohexanecarboxamide with cobalt
0.004
acetylspermidine, pH 7.5
0.008
acetylcadaverine, pH 7.5
0.011
acetylputrescine, pH 7.5
0.0135
-
substrate cyclohexanecarboxamide with cobalt
0.019
-
growth substrate succinate, 2-chloropropionamide-amidase activity, measured with 80 mM 2-chloropropionamide, strain PPW3
0.023
-
growth substrate 2-monochloropropionic acid, 2-chloropropionamide-amidase activity, measured with 80 mM 2-chloropropionamide, strain PPW3
0.0306
-
C203A mutant, supernatant of cell-free extract, 10.8% of wild-type activity
0.031
-
growth substrate succinate, 2-chloropropionamide-amidase activity, measured with 80 mM 2-chloropropionamide, strain PAU5
0.039
-
growth substrate propionamide, 2-chloropropionamide-amidase activity, measured with 80 mM 2-chloropropionamide, strain PAU5
0.05
-
substrate acetamide, crude extract
0.078
-
A-amidase, substrate was 2-chloropropionamide
0.12
-
growth substrate 2-chloropropionamide, 2-chloropropionamide-amidase activity, measured with 14 mM 2-chloropropionamide, strain PPW3
0.14
-
growth substrate 2-monochloropropionic acid, 2-chloropropionamide-amidase activity, measured with 80 mM 2-chloropropionamide, strain PAU5
0.162
-
D191E mutant, purified, 1.33% of purified wild-type amidase
0.19
-
>99% enantiomeric excess
0.23
-
strain N6, isobutyramide, pH 7.4, room temperature, 30 min
0.283
-
wild-type amidase
0.3
-
substrate valeramide, strain R312
0.35
-
strain N6-ureB::TnKm-4, isobutyramide, pH 7.4, room temperature, 30 min
0.383
-
strain JM 109 harboring pKPO2(6)
0.468
-
harboring pALJ30, substrate cyclohexanecarboxamide with cobalt
0.55
recombinant purified His-tagged enzyme, pH 8.0, 35°C, substrate 3',4'-dichloropropionanilide
0.6
-
substrate pivalamide, strain R312
0.67
-
activity in cell extract, substrate 1 mM phenylacetamide
0.69
recombinant purified His-tagged enzyme, pH 8.0, 35°C, substrate 2',6'-dimethylacetanilide
0.81
-
activity in cell extract, substrate 1 mM ketoprofen amide
0.87
recombinant purified His-tagged enzyme, pH 8.0, 35°C, substrate 4'-methylacetanilide
0.89
-
strain B6, substrate para-nitroacetanilide, pH 7.2, 25°C
0.91
-
strain L10, substrate para-nitroacetanilide, pH 7.2, 25°C
0.914
-
strain PPW, activity of C-amidase after preparative PAGE, final yield 17% of original activity
1.18
85°C, pH not specified in the publication, substrate: benzamide
1.3
-
activity in cell extract, substrate 1 mM naproxen amide
1.4
-
C203Amutant, purified, 11.5% of purified wild-type amidase
1.51
-
mutant strain MM15 measured with acrylamide as substrate, growth conditions is continuous
1.89
-
strain PPW3, C-amidase, substrate 2-chloropropionamide
10
-
purified enzyme, pH 7.5, 30°C
1000
substrate: acetamide, pH 7.6, 60°C
10000
-
strain RB971 harboring pGL100 without lactose
11
-
strain N6, acrylamide, pH 7.4, room temperature, 30 min
11.6
-
wild-type amidase after purification
12
-
strain N6, propionamide, pH 7.4, room temperature, 30 min
121
-
substrate 2-nitroacetanilide, pure enzyme, pH 8.6 and 30°C
125
-
substrate acetanilide, after disc electrophoresis of purified enzyme
131
-
substrate acetanilide, after purification
133
-
substrate acetanilide, pure enzyme, pH 8.6 and 30°C
135
-
substrate acetamide, strain R312, transfer reaction
14.33
purified recombinant wild-type enzyme, pH 7.0, 35°C, substrate acrylamides
14.8
-
purified recombinant His6-tagged enzyme
143
hexanamide: pH 7.6, 60°C
1430
L-glutamine: pH 7.6, 60°C
149
-
substrate phenylacetate, pure enzyme, pH 8.6 and 30°C
16.39
-
substrate hexanamide
16.5
-
specific activity of S(+)-2-phenylpropionic acid
16.7
-
substrate propionamide, strain R312
1600
-
strain HB101 harboring pGL80
17
-
strain N6-ureB::TnKm-4, acetamide, pH 7.4, room temperature, 30 min
17.7
-
turnover propionamide to propionate and ammonia
1700
-
strain HB101 harboring pGL81
181
-
substrate 4-nitrophenylacetate, pure enzyme, pH 8.6 and 30°C
19.4
-
purified enzyme, substrate benzamide
2.1
-
mutant strain MM15 measured with acetamide as substrate
2.35
-
strain OUCH, substrate para-nitroacetanilide, pH 7.2, 25°C
23.5
-
purified enzyme, substrate methacrylamide
25.4
-
purified enzyme, substrate propionamide
26.8
-
purified enzyme, substrate acrylamide
274.1
-
micromol of NH3 * min-1 * mg of protein-1
2900
-
substrate acetamide, hydrolysis, strain AIU1N
3.5
purified recombinant enzyme, substrate glutaryl-nitro-5-amino benzoic acid
3.59
-
mutant strain MM15 measured with acrylamide as substrate, growth conditions is fed-batch
30.49
-
purified native enzyme, pH 8.0, 50°C
3500
-
micromol of NH3 * min-1 * mg of protein-1
37.5
-
reombinant enzyme in crude extract, at pH 7 and 50°C
37.6
-
micromol of NH3 * min-1 * mg of protein-1
39.82
purified recombinant wild-type enzyme, pH 7.0, 35°C, substrate benzamide
4.1
-
activity after purification, substrate 5 mM phenylacetamide
4.67
purified recombinant enzyme, substrate adipoyl-nitro-5-amino benzoic acid
4.83
-
substrate methacrylamide
4.89
-
strain AIU1N, substrate para-nitroacetanilide, pH 7.2, 25°C
4100
-
substrate acetamide, hydrolysis, strain AI3
48.66
-
purified native enzyme, pH 6.5, 70°C, substrate nicotinamide
50
-
strain N6, urea, pH 7.4, room temperature, 30 min
5000
-
substrate isobutyramide
5900
-
substrate acrylamide
6.5
-
strain N6, acetamide, pH 7.4, room temperature, 30 min
6.69
-
substrate cyclohexanamide
600
-
strain RB971 harboring pGL100 with lactose
65
-
strain N6-836, urea, pH 7.4, room temperature, 30 min
67
acrylamide: pH 7.6, 60°C
7.7
-
substrate 4-nitroacetanilide, crude extract
73
-
substrate phenacetin, pure enzyme, pH 8.6 and 30°C
7700
-
substrate butyramide
8.04
-
strain AI3, substrate para-nitroacetanilide, pH 7.2, 25°C
0.2
-
strain N6-836, formamide, pH 7.4, room temperature, 30 min
0.2
-
strain N6-ureB::TnKm-4, formamide, pH 7.4, room temperature, 30 min
0.25
-
strain N6, formamide, pH 7.4, room temperature, 30 min
0.25
-
growth substrate 2-chloropropionamide, 2-chloropropionamide-amidase activity, measured with 14 mM 2-chloropropionamide, strain PAU5
0.8
-
substrate benzamide, strain R312
0.8
-
at 3 mM formamide, formamidase activity of AI3 amidase
1.5
-
substrate 4-nitro-acetanilide, strain OUCH4
1.5
-
4-nitroacetanilide, strain OUCH 4, pH 8.5
10.5
-
substrate 4-nitro-acetanilide, strain AI3 25-fold greater activity than wild-type
10.5
-
4-nitroacetanilide, strain AI3, pH 8.5
12.2
-
substrate benzamide
12.2
-
transformant, substrate benzamide
12.2
-
purified from a soluble fraction
12.2
-
wild-type amidase, purified
16
-
substrate DL-lactamide, strain R312
16
-
purified recombinant wild-type enzyme
221
-
-
221
-
recombinant enzyme after 6fold purification, at pH 7 and 50°C
28
-
strain N6-ureB::TnKm-4, acrylamide, pH 7.4, room temperature, 30 min
28
-
strain N6-ureB::TnKm-4, propionamide, pH 7.4, room temperature, 30 min
7.4
-
substrate 4-nitro-acetanilide, strain AIU1N
7.4
-
4-nitroacetanilide, strain AIU 1N, pH 8.5
9
-
substrate acetamide, strain R312
9
-
substrate isobutyramide, strain R312
additional information
-
in the presence of hydroxylamine, the amidase would convert acetamide to acetohydroxamic acid rather than to ammonium acetate
additional information
-
initial reaction rates, partially purified recombinant enzyme
additional information
-
activity in U/microliter: 380.0 with Gly-Gly, 10.0 without Gly-Gly
additional information
-
effects of specific monoclonal antibodies on wild-type and mutant enzyme activity
additional information
-
effects of specific monoclonal antibodies on wild-type and mutant enzyme activity
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.